rfhg_139992.1

Basic information about the TSS

---

TSS ID: rfhg_139992.1 Species: human Chr: chr11		Start: 67119247 End: 67119291 Strand: +
Source datasets	PRJNA4843412|DRA013844|PRJNA401781|PRJNA548673|PRJNA615891
Protocol	NETCAGE|CAGE|ReCappable-seq|SLIC_CAGE|TIF-seq2
TSS cluster detected*	7

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	PLS,CTCF-bound (EH38D2461676,EH38E1546762)
Category:	PLS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000529006.7:0 ENST00000398645.6:0 BC047486:0 GeneID: 22992 HGNC/MGI_ID: HGNC:13606 UniProt_ID: I3VM53 Q9Y2K7 Nearer transcript ids and distances:

Gene_name: KDM2A Gene_symbol: KDM2A Gene_synonyms: CXXC8 DKFZP434M1735 FBL11 FBL7 FLJ00115 JHDM1A KIAA1004 LILINA Gene_source: HGNC:13606

TATA-Box annotation

---

Distance to TSS:	6
Nearest PromoterID:	NR_027473
Entrez ID:	22992
Nearest Unigene:	Hs.124147
Nearest Refseq:	NM_012308
Nearest Ensembl:	ENSG00000173120
Gene Name:	KDM2A
Gene Alias:	CXXC8|FBL11|FBL7|FBXL11|JHDM1A|LILINA
Gene Type:	protein-coding
CpG%:	0.045455
GC%:	0.533333
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@KDM2A p2@KDM2A p3@KDM2A p4@KDM2A p5@KDM2A p6@KDM2A p7@KDM2A
Sample		p1@KDM2A	p2@KDM2A	p3@KDM2A	p4@KDM2A	p5@KDM2A	p6@KDM2A	p7@KDM2A
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	20.84	15.97	4.68	1.17	1.17	0.19	0.58
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	19.62	17.80	3.84	1.42	0.61	0.40	0.20
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	21.22	15.24	2.51	0.58	1.54	0.39	0.39
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	13.51	16.01	2.29	0.83	0.83	0.42	0.42
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	16.65	16.20	3.82	0.90	1.12	0.22	0.22
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	16.86	14.73	4.07	0.97	0.97	0.58	0.00
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	18.96	16.12	2.83	1.09	2.18	0.87	0.00
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	15.74	16.23	3.63	1.94	0.97	0.24	0.00
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	17.31	14.75	3.21	0.85	1.07	0.21	0.43
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	21.45	35.94	4.64	1.74	2.32	0.00	0.00
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	17.79	26.28	3.64	1.62	0.81	2.83	0.40
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	19.92	30.08	1.63	1.63	2.44	0.81	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	16.76	2.10	2.26	0.32	0.32	0.00	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	13.53	1.80	2.71	0.30	0.30	0.00	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	13.61	2.85	3.07	0.00	0.00	0.22	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	10.81	3.27	2.26	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	10.92	1.53	3.28	0.44	0.00	0.00	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	9.70	1.69	2.95	0.42	0.00	0.00	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	10.13	3.20	5.33	0.00	0.00	0.53	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	10.98	4.36	3.16	0.00	0.45	0.60	0.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	13.63	2.67	4.68	0.27	0.40	0.53	0.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	12.60	7.25	5.35	0.86	0.35	0.69	0.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	8.92	4.91	3.88	0.13	0.52	0.00	0.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	11.89	4.37	2.43	0.73	0.24	0.24	0.73
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	10.58	6.19	3.10	1.29	0.26	0.26	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	9.81	6.96	2.85	0.63	0.00	0.00	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	8.79	8.24	2.20	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	14.15	5.19	5.89	0.24	0.71	0.94	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	9.69	6.62	3.39	0.81	0.48	0.16	0.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	10.86	7.06	3.08	0.00	0.54	0.36	0.18
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	7.75	5.44	4.19	0.42	0.21	0.00	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	6.06	8.01	3.71	0.39	0.39	0.20	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	6.54	6.96	4.43	0.84	0.42	0.63	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	6.60	5.28	3.13	0.49	0.33	0.33	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	6.54	4.67	1.12	0.56	0.00	0.37	0.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	8.24	3.83	2.87	0.57	0.38	0.57	0.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	6.54	7.15	4.70	0.20	0.41	0.20	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	6.45	5.64	1.61	0.81	0.00	0.20	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	5.40	6.48	3.51	0.00	0.54	0.27	0.54
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	5.04	6.96	5.28	1.44	0.24	0.96	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	7.29	6.59	4.47	0.71	0.24	0.24	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	7.91	7.17	4.25	1.46	0.44	0.15	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	5.06	8.86	5.27	1.27	0.84	0.00	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	10.14	8.74	4.72	1.22	1.05	0.52	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	7.63	12.25	6.22	2.21	0.80	0.40	0.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	5.82	10.47	5.82	2.33	0.23	0.70	0.70
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	6.48	8.16	4.08	1.20	0.24	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	7.15	12.52	6.56	0.60	0.60	0.30	0.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	9.57	9.34	4.55	0.96	0.00	0.48	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	8.09	6.67	6.87	1.21	0.61	0.40	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	7.38	12.91	6.97	1.43	0.20	0.00	0.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	11.12	13.34	8.01	2.00	0.44	0.22	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	69.96	0.00	27.98	0.00	0.00	0.00	13.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	9.23	9.23	6.03	0.71	1.42	0.35	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	7.62	10.94	8.95	0.99	0.99	0.66	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	16.78	8.39	8.39	2.52	0.84	0.84	1.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	13.32	11.48	6.89	0.92	0.92	1.38	1.38
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	8.75	12.64	11.99	0.65	0.00	0.97	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	3.85	8.03	9.64	1.28	0.32	0.00	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	9.12	17.29	10.06	1.26	0.63	0.63	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	5.64	13.40	7.76	1.41	0.71	0.71	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	6.73	12.34	7.85	0.00	1.68	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	5.57	17.52	6.37	0.00	1.59	0.80	0.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	7.81	18.35	10.19	1.02	0.68	1.02	0.34
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	7.47	17.22	11.70	2.92	1.30	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	6.39	10.29	9.94	1.42	0.35	0.71	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	32.33	16.16	16.16	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	39.49	39.49	0.00	7.90	7.90	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	6.34	12.68	6.83	0.49	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	11.90	7.44	6.94	0.50	0.50	0.00	0.50
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	8.91	11.26	7.04	1.41	0.47	0.94	0.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	6.62	8.61	9.94	0.66	0.33	0.33	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	5.26	4.95	9.28	0.31	0.62	0.31	0.62
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	5.81	6.42	7.03	1.22	1.22	0.61	0.31
Adipocyte - breast, donor1	11376-118A8	14.41	3.96	4.28	0.48	0.32	0.32	0.16
Adipocyte - breast, donor2	11327-117E4	9.47	3.05	2.57	0.16	0.00	0.16	0.00
Adipocyte - omental, donor1	11473-119C6	18.45	3.69	2.29	0.38	0.51	0.00	0.76
Adipocyte - omental, donor2	11474-119C7	3.74	2.99	1.49	0.75	0.75	0.00	0.75
Adipocyte - omental, donor3	11475-119C8	6.36	3.68	2.01	0.33	1.00	0.33	0.00
Adipocyte - perirenal, donor1	11476-119C9	6.38	3.19	2.55	0.00	0.00	0.00	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	5.50	1.10	1.10	2.20	0.00	1.10	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	9.03	4.52	3.61	0.45	0.90	0.45	0.00
Adipocyte - subcutaneous, donor3	11408-118E4	12.16	0.87	1.04	0.70	0.52	0.00	0.17
Adipocyte differentiation, day04, donor1	13019-139D4	26.60	8.61	4.69	0.20	0.98	0.00	0.20
Adipocyte differentiation, day04, donor2	13022-139D7	19.05	7.98	2.06	0.26	0.00	0.00	0.51
Adipocyte differentiation, day04, donor3	13025-139E1	16.73	15.05	6.97	0.00	0.84	0.00	0.28
Adipocyte differentiation, day04, donor4	13028-139E4	19.99	9.40	3.53	1.18	0.59	0.00	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	18.74	10.30	3.86	0.97	0.24	0.08	0.40
Adipocyte differentiation, day08, donor2	13023-139D8	19.69	9.36	2.26	0.65	0.00	0.00	0.32
Adipocyte differentiation, day08, donor3	13026-139E2	13.33	13.33	3.73	0.53	0.53	0.00	0.53
Adipocyte differentiation, day08, donor4	13029-139E5	15.58	13.91	5.56	1.11	1.67	0.00	1.11
Adipocyte differentiation, day12, donor1	13021-139D6	9.98	8.32	2.08	0.42	0.83	0.42	0.83
Adipocyte differentiation, day12, donor2	13024-139D9	15.32	9.04	4.27	0.50	0.00	0.00	1.26
Adipocyte differentiation, day12, donor3	13027-139E3	12.11	9.16	4.25	0.33	0.98	0.00	0.33
Adipocyte differentiation, day12, donor4	13030-139E6	8.83	10.05	1.52	0.30	0.00	0.00	0.00
Alveolar Epithelial Cells, donor1	11510-119G7	14.14	8.40	5.75	0.66	1.33	0.44	0.44
Alveolar Epithelial Cells, donor2	11590-120G6	6.81	5.38	6.10	0.36	0.72	0.72	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	8.39	1.20	1.20	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	14.57	12.41	6.30	0.90	0.90	0.18	0.36
Amniotic Epithelial Cells, donor2	11613-122A2	18.41	8.37	1.67	0.00	1.67	1.67	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	16.85	10.68	3.49	1.85	0.82	0.00	0.00
Anulus Pulposus Cell, donor1	11248-116E6	13.96	1.72	2.06	0.00	0.11	0.00	0.34
Anulus Pulposus Cell, donor2	11463-119B5	8.33	2.45	2.20	0.24	0.49	0.00	0.49
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	4.94	8.99	2.70	0.45	0.90	0.45	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	7.81	2.60	5.64	0.87	0.00	0.00	0.43
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	10.70	10.70	4.28	4.28	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	8.97	7.77	3.59	0.30	0.00	1.79	0.30
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	2.53	6.32	5.06	1.26	1.26	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	5.94	10.56	6.60	0.00	0.66	1.32	0.66
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	5.85	7.80	4.22	0.32	0.00	0.32	0.32
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	5.34	9.22	3.40	0.00	0.00	0.49	0.49
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	8.91	7.13	5.94	0.00	0.00	1.19	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	8.29	10.17	5.27	0.00	0.00	0.38	0.38
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	7.26	6.53	2.18	0.00	0.00	0.73	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	5.02	6.27	6.27	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	6.59	5.93	4.28	0.49	0.49	0.00	0.16
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	8.19	6.82	4.09	0.00	1.36	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	5.88	5.43	3.62	0.45	0.30	0.45	0.15
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	4.82	11.79	4.82	0.00	0.00	0.54	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	6.05	7.18	5.29	0.76	0.38	0.57	0.19
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	7.22	12.30	7.75	0.27	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	7.80	6.83	4.88	0.00	0.98	0.98	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	6.14	4.48	4.48	0.00	0.50	0.66	0.33
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	7.20	13.21	7.20	1.20	0.00	1.20	1.20
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	14.16	7.08	3.54	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	9.78	3.95	4.97	0.51	0.00	0.34	0.51
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	25.17	8.39	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	10.19	5.83	2.91	0.00	0.00	0.49	0.49
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	7.97	4.55	5.69	1.14	0.00	1.14	0.38
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	8.48	7.27	2.42	0.00	1.21	1.21	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	8.55	3.99	5.70	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	7.70	5.13	5.13	0.21	0.21	0.43	0.21
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	6.19	6.45	2.84	0.26	0.00	0.52	0.26
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	5.63	6.10	3.75	0.00	0.94	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	5.14	4.82	3.54	0.32	0.00	0.64	0.96
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	3.57	9.27	1.43	0.71	0.00	0.71	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	7.02	4.09	3.51	0.00	0.58	0.58	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	6.02	3.91	6.02	0.90	0.90	0.60	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	3.56	4.75	5.94	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	8.65	7.12	3.56	0.51	0.00	0.00	0.51
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	4.58	6.37	4.08	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	3.81	6.99	3.18	0.64	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	5.18	6.04	2.16	0.00	0.43	0.86	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	5.93	6.14	4.02	0.42	0.42	0.42	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	5.80	4.93	3.19	0.58	0.58	0.29	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	5.67	5.67	4.72	0.00	0.94	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	4.58	5.59	2.71	0.17	0.34	0.17	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	0.00	16.21	4.63	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	2.11	4.23	0.00	2.11	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	5.79	8.79	4.93	1.29	0.21	0.86	0.21
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	4.21	10.83	4.21	1.20	0.00	0.60	0.60
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	5.10	7.29	5.10	0.00	0.00	0.73	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	7.59	5.98	5.98	0.00	0.23	0.23	0.23
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	2.55	10.20	7.65	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	7.12	7.88	4.07	0.51	0.51	1.78	0.25
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	6.61	10.53	5.57	0.62	0.83	0.21	0.41
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	8.26	8.26	5.51	1.22	0.61	0.31	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	4.30	10.52	5.74	0.00	0.96	0.00	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	6.21	5.54	5.54	0.22	0.89	0.22	0.44
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	3.05	9.15	6.10	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	10.52	9.97	6.09	0.00	0.00	0.55	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	7.15	3.97	8.21	0.00	0.79	0.53	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	7.63	8.36	2.54	0.36	0.36	0.00	0.36
Astrocyte - cerebellum, donor1	11500-119F6	16.09	4.42	5.28	0.25	0.37	0.61	0.12
Astrocyte - cerebellum, donor2	11580-120F5	8.90	3.25	4.96	0.51	0.51	0.34	0.51
Astrocyte - cerebellum, donor3	11661-122F5	17.20	2.31	3.57	0.21	0.21	0.21	0.21
Astrocyte - cerebral cortex, donor1	11235-116D2	23.01	4.53	4.88	0.35	0.00	0.35	0.00
Astrocyte - cerebral cortex, donor2	11316-117D2	19.90	7.93	3.88	0.97	0.32	0.00	0.16
Astrocyte - cerebral cortex, donor3	11392-118C6	19.99	5.97	4.92	0.60	0.75	0.15	0.30
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	47.25	20.18	14.34	3.56	2.29	0.69	2.29
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	37.84	26.56	19.42	4.26	2.63	1.13	0.50
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	40.74	21.62	15.36	2.39	4.10	0.57	1.14
Basophils, donor1	12241-129G9	47.86	25.11	46.81	3.14	4.18	7.06	1.05
Basophils, donor2	12242-129H1	51.23	51.59	120.14	4.69	10.82	32.11	3.61
Basophils, donor3	12243-129H2	51.16	20.58	30.58	1.76	3.38	5.59	1.03
Bronchial Epithelial Cell, donor1	11511-119G8	20.91	4.10	3.45	1.29	0.65	0.00	0.43
Bronchial Epithelial Cell, donor2	11591-120G7	8.23	3.66	2.74	0.46	0.00	0.00	0.46
Bronchial Epithelial Cell, donor3	11672-122G7	7.17	14.35	7.17	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	3.77	5.65	4.39	0.63	0.00	1.26	0.63
Bronchial Epithelial Cell, donor5	11457-119A8	7.49	8.32	3.54	0.62	0.83	0.21	0.42
Bronchial Epithelial Cell, donor6	11461-119B3	8.98	3.68	2.76	0.23	0.00	0.46	0.00
Bronchial Epithelial Cell, donor7	11769-123I5	17.99	3.42	1.44	0.36	0.00	0.00	0.36
Burkitt's lymphoma cell line:DAUDI	10422-106C8	22.88	8.24	10.82	0.41	0.72	1.03	0.52
Burkitt's lymphoma cell line:RAJI	10476-106I8	28.18	16.07	15.60	0.93	1.63	2.10	0.47
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	29.10	17.59	26.86	3.84	3.20	3.84	0.32
CD133+ stem cells - cord blood derived, pool1	12223-129E9	20.68	20.68	134.45	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	73.83	16.34	25.36	1.13	1.69	3.94	1.13
CD14+ Monocytes, donor2	11305-117B9	53.27	19.67	35.45	2.41	3.16	4.83	1.48
CD14+ Monocytes, donor3	11381-118B4	64.10	23.05	31.39	2.41	4.17	4.83	3.73
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	40.76	6.79	7.64	0.00	0.00	0.57	0.00
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	34.87	8.34	7.20	0.00	0.76	0.38	1.14
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	32.22	4.60	6.57	0.33	0.66	0.66	0.33
CD14+ monocytes - mock treated, donor1	11863-125A9	67.36	8.38	4.19	0.29	0.72	0.29	0.00
CD14+ monocytes - mock treated, donor2	11873-125C1	42.55	6.34	3.02	0.60	0.30	0.30	0.00
CD14+ monocytes - mock treated, donor3	11883-125D2	62.78	14.21	7.34	0.95	0.95	0.47	0.95
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	41.35	8.87	3.35	0.67	0.50	0.50	0.17
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	33.12	8.83	2.76	0.28	0.28	0.00	0.00
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	30.00	6.69	3.72	0.25	0.74	0.74	0.25
CD14+ monocytes - treated with BCG, donor1	11860-125A6	35.44	1.76	0.59	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with BCG, donor2	11870-125B7	37.21	3.20	2.49	0.00	0.18	0.18	0.00
CD14+ monocytes - treated with BCG, donor3	11880-125C8	38.74	4.35	5.01	0.22	0.65	0.22	0.22
CD14+ monocytes - treated with Candida, donor1	11868-125B5	43.31	5.38	0.94	0.94	0.00	0.00	0.00
CD14+ monocytes - treated with Candida, donor2	11878-125C6	40.13	5.28	5.81	0.53	0.53	0.53	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	51.03	4.44	2.22	1.11	0.00	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	48.64	8.03	2.38	0.30	0.15	0.15	0.15
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	36.32	8.78	5.19	0.40	0.60	0.20	0.00
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	40.18	7.29	4.58	0.21	1.04	1.25	0.00
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	46.90	6.18	3.89	0.46	0.69	0.69	0.00
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	40.26	7.69	2.04	0.23	0.90	0.45	0.23
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	35.79	9.17	0.44	0.00	0.44	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	50.84	2.42	1.61	0.00	0.27	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	51.99	5.58	2.27	0.35	0.35	0.17	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	53.44	5.47	5.89	0.42	0.00	0.42	0.00
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	24.80	3.86	2.20	0.00	0.00	0.55	0.00
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	19.37	8.10	3.52	0.00	0.35	0.00	0.35
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	25.88	6.58	4.39	0.44	0.44	0.44	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	37.32	2.62	1.05	0.00	0.17	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	37.54	2.97	2.23	0.74	0.00	0.74	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	43.97	3.88	3.23	0.00	0.22	0.22	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	25.39	7.78	5.73	0.00	0.82	0.41	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	22.25	7.42	7.19	0.00	0.23	0.93	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	21.81	5.80	3.94	0.46	1.16	0.93	0.23
CD14+CD16+ Monocytes, donor1	11789-124B7	28.55	9.37	7.19	1.31	0.87	0.87	0.87
CD14+CD16+ Monocytes, donor2	11801-124D1	41.81	9.47	11.09	1.62	2.08	2.54	1.39
CD14+CD16+ Monocytes, donor3	11912-125G4	35.31	9.75	7.58	1.30	1.73	0.65	0.43
CD14+CD16- Monocytes, donor1	11788-124B6	78.02	8.56	6.70	1.40	1.25	2.02	0.31
CD14+CD16- Monocytes, donor2	11799-124C8	55.89	8.56	8.38	1.22	1.40	1.05	0.35
CD14+CD16- Monocytes, donor3	11910-125G2	76.70	8.25	16.72	1.34	2.68	2.01	0.89
CD14-CD16+ Monocytes, donor1	11790-124B8	53.33	9.44	6.63	2.30	1.53	0.26	0.51
CD14-CD16+ Monocytes, donor2	11800-124C9	43.03	8.34	5.49	1.54	0.44	1.76	0.88
CD14-CD16+ Monocytes, donor3	11911-125G3	42.32	7.58	4.00	1.68	1.47	0.42	0.21
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	36.58	32.52	52.84	6.10	6.10	4.06	4.06
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	24.41	33.90	39.32	3.39	1.36	2.71	1.36
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	42.46	31.07	50.74	5.18	4.14	4.14	6.21
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	77.82	37.31	37.31	4.80	2.67	1.60	2.13
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	57.36	24.12	44.49	6.97	3.75	3.75	2.68
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	44.92	32.99	49.84	3.51	4.21	4.21	2.81
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	42.36	36.08	37.65	3.92	8.63	3.14	3.92
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	48.78	36.91	51.41	3.95	5.27	1.32	2.64
CD19+ B Cells, donor1	11544-120B5	31.23	69.04	108.49	13.97	21.37	13.15	4.11
CD19+ B Cells, donor2	11624-122B4	27.57	90.68	128.40	7.98	15.96	15.23	9.43
CD19+ B Cells, donor3	11705-123B4	33.82	75.72	134.79	8.58	18.17	13.63	6.56
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	41.21	4.04	6.06	0.40	0.40	0.00	1.21
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	35.16	3.60	3.60	0.80	0.80	0.00	0.40
CD34+ Progenitors, donor1	11545-120B6	15.06	16.06	43.17	2.01	7.03	6.02	2.01
CD34+ Progenitors, donor2	11625-122B5	17.98	35.96	56.74	2.81	6.74	6.74	1.69
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	28.56	7.14	22.55	1.50	1.50	2.25	0.75
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	20.52	15.56	22.10	1.35	1.58	3.61	0.90
CD4+ T Cells, donor1	11225-116C1	50.70	157.11	297.07	20.00	22.49	17.85	12.85
CD4+ T Cells, donor2	11306-117C1	47.15	146.35	263.32	7.96	34.29	27.56	15.31
CD4+ T Cells, donor3	11382-118B5	43.00	113.46	162.87	12.50	13.42	17.69	6.71
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	33.18	23.74	61.26	1.28	2.55	3.83	2.04
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	44.25	25.15	53.90	1.12	4.94	2.92	0.90
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	47.14	32.20	59.50	0.57	2.87	2.87	1.72
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	40.77	27.97	97.19	2.84	4.27	6.16	4.74
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	40.73	25.28	105.35	4.21	6.32	7.02	4.21
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	29.67	49.44	82.41	0.00	6.59	3.30	3.30
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	28.61	27.89	46.53	1.30	3.90	7.51	1.88
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	32.37	31.01	43.89	1.53	3.39	3.39	1.69
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	27.89	34.98	56.58	1.29	3.55	3.22	1.29
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	44.38	34.97	79.35	2.24	4.48	15.24	3.14
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	40.53	24.81	77.56	2.80	4.19	9.78	3.14
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	33.88	29.48	133.75	3.96	6.16	18.92	3.96
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	25.30	24.46	42.16	0.84	4.64	5.48	3.37
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	27.43	22.44	33.24	0.62	3.74	2.49	0.83
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	19.71	15.04	32.74	1.67	3.68	2.34	0.67
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	41.06	49.76	120.74	5.98	7.89	3.26	6.53
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	37.52	49.84	153.82	5.36	5.36	4.29	4.82
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	23.31	37.66	125.53	1.79	0.00	8.97	8.97
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	43.76	17.24	28.93	0.93	2.23	4.45	1.67
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	37.26	15.60	29.03	0.22	3.03	3.90	1.08
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	44.34	13.87	30.89	1.05	2.94	3.57	1.05
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	39.94	75.84	124.38	7.58	16.18	13.65	3.54
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	41.16	57.19	110.05	2.17	12.13	12.13	4.77
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	35.30	65.81	169.97	6.10	12.64	19.61	5.23
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	49.49	20.78	70.77	1.48	4.45	5.94	4.45
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	47.08	13.85	39.70	0.00	1.85	2.77	0.92
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	44.67	18.15	32.10	0.00	4.19	6.98	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	35.17	26.59	73.94	1.38	4.43	6.65	3.60
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	35.58	22.82	74.84	1.96	3.93	3.44	1.23
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	33.88	4.62	64.68	0.00	4.62	6.16	3.08
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	51.57	21.49	51.57	1.79	3.22	6.45	0.72
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	48.47	31.85	47.09	0.00	2.77	2.77	4.15
CD8+ T Cells, donor1	11226-116C2	49.11	139.14	197.09	15.06	17.68	32.08	8.18
CD8+ T Cells, donor2	11307-117C2	37.92	127.65	178.71	10.14	11.26	19.90	6.38
CD8+ T Cells, donor3	11383-118B6	39.39	126.24	205.02	14.14	19.95	20.45	9.85
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	4.82	11.47	5.51	0.69	0.23	0.92	0.69
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	5.99	14.14	7.43	0.96	0.24	0.96	0.24
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	4.65	12.31	3.28	0.00	1.64	0.82	1.09
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	7.51	15.91	8.11	0.90	0.60	0.30	0.60
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	6.48	13.92	5.76	0.96	0.72	0.96	0.48
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	7.28	12.73	3.64	1.14	0.45	1.36	0.00
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	7.82	16.95	5.21	0.65	0.87	0.43	0.87
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	9.48	20.27	3.16	2.11	1.58	1.32	0.00
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	11.26	18.76	4.69	0.94	1.41	0.23	0.00
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	10.57	20.53	7.25	0.00	1.51	0.00	0.00
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	10.17	17.72	5.81	0.00	0.58	0.87	0.58
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	8.53	19.45	6.13	0.27	0.53	1.07	0.27
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	19.26	26.70	6.13	1.75	0.88	0.88	0.88
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	15.94	25.50	4.55	2.73	0.46	1.37	0.00
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	15.66	29.09	4.48	0.75	0.75	0.75	0.75
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	7.92	18.73	6.12	1.08	0.36	1.44	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	7.19	12.37	6.33	0.86	0.58	0.29	0.86
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	8.01	10.84	6.36	0.47	0.71	0.00	0.94
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	11.09	18.70	3.17	0.63	0.32	0.00	0.63
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	14.15	17.53	4.61	0.92	0.92	0.92	0.92
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	8.66	17.63	6.41	1.60	1.28	0.64	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	9.18	16.83	3.06	0.38	0.76	0.76	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	8.28	8.67	3.55	1.18	0.39	0.39	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	7.56	19.67	4.54	0.00	0.76	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	28.91	39.34	4.82	4.01	2.41	0.80	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	25.88	39.87	7.69	2.80	0.70	0.00	0.70
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	34.06	42.07	6.01	4.01	1.00	0.00	1.00
Cardiac Myocyte, donor1	11525-119I4	12.79	0.00	3.66	0.00	0.00	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	12.35	2.96	1.48	0.00	0.49	0.00	0.49
Cardiac Myocyte, donor3	11686-122I3	14.00	2.00	1.16	0.32	0.11	0.11	0.00
Chondrocyte - de diff, donor1	11261-116G1	10.75	4.85	3.81	0.00	0.69	0.00	0.35
Chondrocyte - de diff, donor2	11338-117F6	18.83	2.49	1.07	0.36	0.36	0.36	0.71
Chondrocyte - de diff, donor3	11410-118E6	12.74	2.73	1.14	0.46	0.11	0.00	0.00
Chondrocyte - re diff, donor2	11339-117F7	12.53	5.37	11.64	0.00	0.00	0.00	0.00
Chondrocyte - re diff, donor3	11411-118E7	36.80	4.45	2.02	0.40	0.40	0.00	0.00
Ciliary Epithelial Cells, donor1	11242-116D9	19.51	8.61	4.59	0.80	0.34	0.46	0.34
Ciliary Epithelial Cells, donor2	11323-117D9	11.54	8.55	4.49	0.64	0.64	0.00	1.28
Ciliary Epithelial Cells, donor3	11399-118D4	12.74	6.37	6.28	0.53	0.44	0.27	0.18
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	45.02	9.90	10.82	2.29	1.38	0.83	0.64
Corneal Epithelial Cells, donor1	11526-119I5	10.54	6.81	5.71	2.42	0.44	0.00	0.22
Corneal Epithelial Cells, donor2	11606-120I4	17.06	12.51	4.55	1.14	0.00	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	15.08	9.71	5.11	1.28	1.28	0.00	0.00
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	23.44	16.18	4.29	1.82	0.83	0.00	0.33
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	21.45	13.88	2.52	1.26	0.00	0.00	0.63
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	10.35	3.45	10.35	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	13.39	9.18	3.02	1.08	0.43	0.22	0.43
Dendritic Cells - plasmacytoid, donor1	11228-116C4	72.09	7.52	24.26	1.02	1.71	1.02	1.02
Dendritic Cells - plasmacytoid, donor2	11309-117C4	46.35	24.81	31.34	1.96	5.22	0.65	3.92
Dendritic Cells - plasmacytoid, donor3	11385-118B8	49.85	7.74	36.30	0.48	5.32	0.97	4.84
Endothelial Cells - Aortic, donor0	11207-116A1	17.34	11.34	8.84	0.00	0.33	2.17	0.00
Endothelial Cells - Aortic, donor1	11263-116G3	7.63	3.52	6.45	0.00	0.59	1.17	0.59
Endothelial Cells - Aortic, donor2	11340-117F8	20.64	7.35	6.22	0.00	0.00	0.57	0.28
Endothelial Cells - Aortic, donor3	11412-118E8	13.76	5.90	7.08	0.00	0.00	1.57	0.39
Endothelial Cells - Artery, donor1	11264-116G4	11.93	10.18	7.56	0.58	0.58	0.29	0.29
Endothelial Cells - Artery, donor2	11341-117F9	13.65	11.29	5.41	0.71	0.47	1.65	0.24
Endothelial Cells - Artery, donor3	11413-118E9	14.90	9.47	7.54	0.53	0.53	1.40	0.18
Endothelial Cells - Lymphatic, donor1	11236-116D3	20.17	6.21	4.43	0.00	0.66	1.11	0.22
Endothelial Cells - Lymphatic, donor2	11317-117D3	18.86	5.17	6.39	0.30	0.61	0.91	0.61
Endothelial Cells - Lymphatic, donor3	11393-118C7	19.17	6.20	6.48	0.56	0.56	0.28	0.00
Endothelial Cells - Microvascular, donor1	11265-116G5	10.99	9.81	7.13	1.49	0.00	0.89	0.00
Endothelial Cells - Microvascular, donor2	11342-117G1	7.29	9.37	8.33	1.04	0.00	0.52	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	11.34	4.68	4.40	0.14	0.14	0.71	0.14
Endothelial Cells - Thoracic, donor1	11266-116G6	11.60	12.80	9.60	0.00	0.40	2.40	0.00
Endothelial Cells - Thoracic, donor2	11343-117G2	13.10	5.24	3.67	1.05	0.52	1.05	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	22.74	8.32	8.57	0.50	0.75	0.75	0.00
Endothelial Cells - Umbilical vein, donor2	11324-117E1	12.38	8.04	8.26	0.43	0.43	0.43	0.00
Endothelial Cells - Umbilical vein, donor3	11400-118D5	14.53	7.33	6.11	0.24	0.37	0.49	0.00
Endothelial Cells - Vein, donor1	11267-116G7	10.24	10.24	10.24	0.00	0.00	1.14	0.00
Endothelial Cells - Vein, donor2	11344-117G3	16.07	12.57	5.59	0.00	0.70	2.79	0.00
Endothelial Cells - Vein, donor3	11416-118F3	16.01	7.85	5.97	0.16	0.47	0.94	0.16
Eosinophils, donor1	12244-129H3	60.99	91.48	121.98	15.25	0.00	60.99	0.00
Eosinophils, donor2	12245-129H4	212.88	28.05	41.26	0.00	1.65	4.95	3.30
Eosinophils, donor3	12246-129H5	196.18	17.83	17.83	0.00	0.00	7.13	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	14.17	7.09	2.93	0.49	0.00	0.24	0.00
Esophageal Epithelial Cells, donor2	11587-120G3	8.32	2.08	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	13.55	5.34	1.23	0.41	0.41	0.00	0.00
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	4.05	1.64	0.88	0.00	0.11	0.22	0.00
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	6.39	3.36	1.52	0.22	0.11	0.11	0.00
Fibroblast - Aortic Adventitial, donor1	11245-116E3	17.59	4.73	3.40	0.24	0.12	0.49	0.49
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	24.84	11.33	10.37	0.55	1.09	1.36	0.27
Fibroblast - Aortic Adventitial, donor2	11326-117E3	13.08	3.48	1.58	0.21	0.11	0.42	0.11
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	23.45	10.01	8.70	1.32	1.32	0.53	0.26
Fibroblast - Aortic Adventitial, donor3	11401-118D6	10.30	4.65	4.65	0.00	0.33	0.00	0.00
Fibroblast - Cardiac, donor1	11268-116G8	14.97	3.63	4.99	1.36	0.45	0.00	0.45
Fibroblast - Cardiac, donor2	11345-117G4	18.95	10.61	7.58	0.76	0.76	3.03	0.00
Fibroblast - Cardiac, donor3	11417-118F4	11.83	3.15	1.58	0.47	0.32	0.16	0.00
Fibroblast - Cardiac, donor4	11452-119A3	22.43	3.64	3.33	0.61	0.00	0.30	0.91
Fibroblast - Cardiac, donor5	11456-119A7	10.66	4.44	3.17	0.51	0.38	0.13	0.00
Fibroblast - Cardiac, donor6	11460-119B2	8.49	6.52	4.85	0.15	0.61	0.30	0.45
Fibroblast - Choroid Plexus, donor1	11492-119E7	23.98	3.89	2.14	0.27	0.00	0.00	0.13
Fibroblast - Choroid Plexus, donor2	11572-120E6	20.71	0.43	1.29	0.00	0.00	0.00	0.00
Fibroblast - Choroid Plexus, donor3	11653-122E6	4.39	2.93	2.93	0.00	0.00	0.00	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	26.06	3.00	3.92	0.46	1.15	0.69	0.46
Fibroblast - Conjunctival, donor3	11692-122I9	26.80	1.19	1.19	0.17	0.34	0.00	0.34
Fibroblast - Dermal, donor1	11269-116G9	11.74	2.35	3.52	0.70	0.23	0.00	0.00
Fibroblast - Dermal, donor2	11346-117G5	8.96	3.30	5.19	0.47	0.94	0.94	1.42
Fibroblast - Dermal, donor3	11418-118F5	9.79	3.87	2.54	0.24	0.12	0.12	0.36
Fibroblast - Dermal, donor4	11450-119A1	6.67	3.50	5.54	0.68	0.79	0.23	0.00
Fibroblast - Dermal, donor5	11454-119A5	6.11	5.58	3.66	0.70	0.35	0.35	0.17
Fibroblast - Dermal, donor6	11458-119A9	11.21	7.80	4.39	0.32	0.81	0.00	0.32
Fibroblast - Gingival, donor1	11237-116D4	17.07	1.87	3.54	0.00	0.21	0.00	0.00
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	28.30	6.03	3.14	0.52	0.26	0.00	0.00
Fibroblast - Gingival, donor2	11318-117D4	13.05	4.09	3.29	0.53	0.40	0.40	0.13
Fibroblast - Gingival, donor3	11394-118C8	19.14	0.87	0.97	0.39	0.10	0.00	0.10
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	14.54	5.19	1.04	1.04	1.04	0.00	1.04
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	17.62	4.76	1.06	0.53	0.00	0.00	0.00
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	17.93	7.48	3.27	0.31	0.62	0.00	0.00
Fibroblast - Gingival, donor6 (control)	11922-125H5	13.93	2.84	3.25	0.41	0.54	0.27	0.14
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	13.41	4.94	2.12	0.35	1.76	0.35	1.06
Fibroblast - Gingival, donor7 (control)	11924-125H7	16.53	3.66	2.49	0.15	0.73	0.15	0.44
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	16.23	8.32	3.82	0.68	0.55	0.41	0.00
Fibroblast - Gingival, donor8 (control)	11926-125H9	13.38	11.19	5.16	0.22	0.55	0.55	0.66
Fibroblast - Gingival, donor9 (control)	11927-125I1	37.42	4.55	2.05	0.73	0.29	0.00	0.29
Fibroblast - Lung, donor1	11270-116H1	6.80	2.72	2.72	1.36	0.00	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	22.38	0.00	1.49	1.49	1.49	0.00	0.00
Fibroblast - Lung, donor3	11419-118F6	12.24	5.28	4.01	0.00	0.42	0.21	0.21
Fibroblast - Lymphatic, donor1	11506-119G3	16.66	14.16	6.66	0.00	0.83	0.00	0.83
Fibroblast - Lymphatic, donor2	11586-120G2	11.19	6.99	2.80	0.00	0.00	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	6.16	1.68	1.96	0.56	0.56	0.28	0.00
Fibroblast - Mammary, donor1	11540-120B1	26.39	8.53	4.87	0.41	0.41	0.00	1.22
Fibroblast - Mammary, donor2	11620-122A9	0.00	3.99	0.00	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	11.91	11.91	0.00	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	14.55	2.91	4.07	0.00	0.39	0.00	0.19
Fibroblast - Periodontal Ligament, donor2	11319-117D5	16.23	5.46	2.73	0.46	0.00	0.15	0.15
Fibroblast - Periodontal Ligament, donor3	11395-118C9	18.05	7.65	2.75	0.61	0.00	0.00	0.61
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	17.17	3.43	1.53	0.38	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	13.77	4.86	2.70	0.54	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	14.84	4.41	2.09	0.23	0.46	0.00	0.23
Fibroblast - Pulmonary Artery, donor1	11250-116E8	10.72	4.20	2.65	0.22	0.11	0.55	0.00
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	22.55	5.89	3.66	0.61	0.61	0.00	0.20
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	12.03	6.68	3.34	0.00	1.34	0.67	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	10.67	1.58	1.58	0.40	0.40	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	24.21	13.30	9.33	0.40	0.60	0.79	0.79
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	21.67	2.13	0.89	0.18	0.18	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	22.47	3.74	2.76	0.59	0.20	0.39	0.20
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	19.86	6.32	6.92	0.90	0.60	0.30	0.90
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	13.93	4.86	3.67	0.32	0.54	0.32	0.22
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	22.27	10.12	7.85	0.25	0.51	0.51	0.51
Fibroblast - skin normal, donor1	11553-120C5	14.27	3.61	1.48	0.00	0.00	0.00	0.16
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	35.09	11.43	9.62	0.40	1.80	1.40	0.80
Fibroblast - skin normal, donor2	11561-120D4	14.06	4.42	3.11	0.10	0.10	0.20	0.20
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	29.01	9.97	8.76	0.91	0.91	0.60	0.30
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	28.58	2.24	1.91	0.00	0.25	0.08	0.00
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	13.51	4.44	5.30	0.34	0.51	0.34	0.00
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	13.14	6.57	6.90	0.00	0.99	0.99	0.66
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	13.00	4.90	2.77	0.21	0.53	0.21	0.00
Fibroblast - skin walker warburg, donor1	11554-120C6	20.07	7.08	3.20	0.34	0.67	0.51	0.51
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	10.66	1.25	1.57	0.47	0.00	0.00	0.00
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	66.48	0.00	44.32	0.00	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	21.79	15.69	11.33	1.74	1.74	0.00	0.87
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	14.74	6.41	2.60	1.73	1.04	0.52	0.69
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	20.56	7.29	4.68	0.52	1.04	0.52	0.52
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	12.78	8.18	6.90	0.51	1.02	0.77	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	11.48	27.56	16.84	3.06	2.30	3.06	0.77
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	11.49	28.71	8.93	3.19	3.19	2.55	1.28
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	17.40	27.67	16.83	5.99	2.85	2.57	1.43
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	28.68	6.34	9.93	1.38	0.83	0.55	1.10
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	27.40	13.24	16.21	1.83	2.28	0.91	0.91
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	15.85	20.21	16.05	2.97	2.18	0.79	0.79
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	23.26	6.34	11.90	2.38	1.59	0.79	0.79
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	18.26	16.31	19.24	0.33	0.65	0.33	2.94
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	11.94	23.44	14.59	2.21	2.65	0.88	0.88
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	18.23	5.65	5.79	0.28	0.57	0.85	0.57
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	19.33	5.17	6.40	0.49	0.12	0.12	0.99
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	16.39	7.79	5.10	0.27	0.54	0.00	0.54
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	13.88	6.07	2.85	0.62	0.62	0.25	0.25
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	13.15	4.43	5.81	0.28	0.42	0.28	0.14
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	11.18	6.71	2.64	1.02	0.81	0.41	0.20
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	12.78	5.02	3.19	0.68	0.23	0.23	0.91
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	15.94	4.24	3.49	0.37	0.12	0.25	0.25
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	17.49	8.52	4.37	0.22	0.44	0.22	0.22
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	11.82	3.84	4.73	0.30	1.18	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	19.23	3.34	4.45	0.32	0.16	0.00	0.16
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	13.85	4.47	3.80	0.22	0.45	0.00	0.22
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	11.90	4.84	4.03	0.20	0.40	0.40	0.20
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	16.46	4.92	3.05	0.00	0.17	0.68	0.34
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	21.10	7.27	5.41	0.71	0.89	0.00	0.35
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	19.46	2.60	5.72	1.04	0.42	0.52	0.10
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	16.05	2.39	4.95	0.68	0.17	0.17	0.17
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	15.49	2.32	3.98	0.11	0.00	0.11	0.55
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	19.88	4.74	5.07	0.67	0.17	0.67	0.50
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	17.97	5.31	6.13	0.61	0.61	0.61	0.20
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	13.82	2.68	3.51	0.62	0.00	0.41	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	20.64	3.46	6.34	0.46	0.35	0.23	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	15.68	5.34	4.67	0.17	0.67	0.17	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	12.78	3.53	3.75	0.22	0.66	0.22	0.22
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	18.33	3.44	6.15	0.12	0.25	0.25	0.49
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	16.70	3.57	5.02	0.49	0.49	0.16	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	17.96	1.60	6.74	0.00	0.64	0.64	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	18.00	1.52	3.22	0.47	0.00	0.28	0.09
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	15.82	2.85	3.48	0.32	0.16	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	10.95	1.52	2.43	0.00	1.22	0.30	0.30
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	17.98	2.30	3.03	0.63	0.10	0.31	0.42
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	14.49	2.42	3.07	0.22	0.00	0.44	0.22
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	17.11	2.52	4.21	0.28	0.28	0.56	0.56
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	15.83	2.50	4.54	0.28	0.19	0.09	0.19
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	13.90	1.07	2.94	0.27	0.00	0.00	0.53
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	14.23	2.60	2.91	0.46	0.15	0.31	0.15
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	13.21	1.81	2.33	0.13	0.26	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	11.66	1.08	2.17	0.54	0.00	0.81	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	15.67	2.58	2.58	0.18	0.55	0.18	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	21.27	2.19	1.75	0.22	0.22	0.00	0.88
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	20.83	0.00	1.98	0.00	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	17.54	4.49	2.77	0.13	0.00	0.13	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	15.94	3.43	2.62	0.00	0.20	0.00	0.40
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	25.92	2.80	3.56	0.25	0.00	0.25	0.51
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	13.14	8.16	9.36	1.39	0.80	1.00	1.00
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	13.71	5.08	10.63	0.62	0.92	0.62	0.77
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	21.89	8.80	14.32	0.41	0.41	0.41	1.02
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	15.02	14.39	5.95	0.94	1.56	0.94	0.31
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	13.00	11.58	5.37	2.83	0.85	0.28	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	18.91	14.30	8.76	2.31	1.38	0.46	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	19.80	29.70	12.37	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	17.79	13.15	5.80	0.77	0.39	0.00	0.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	20.86	14.44	4.81	4.81	4.81	1.60	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	34.78	22.60	6.96	0.00	1.74	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	12.04	9.44	3.58	1.30	1.30	0.33	0.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	19.35	8.65	8.65	1.65	1.65	0.00	2.06
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	10.00	6.66	6.66	3.33	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	13.70	7.55	5.03	0.00	0.28	0.28	0.28
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	17.32	6.21	3.27	0.98	0.98	0.00	1.31
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	31.88	4.19	4.19	0.84	0.00	0.00	0.84
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	22.27	5.73	4.77	0.32	1.27	0.00	0.95
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	15.96	10.19	3.40	0.68	0.34	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	10.44	2.09	4.18	2.09	2.09	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	20.62	6.87	5.15	0.00	0.57	0.00	0.57
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	14.80	5.33	2.07	0.89	0.30	0.30	0.59
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	10.16	1.69	0.00	3.39	1.69	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	21.95	7.04	3.31	1.24	0.00	0.83	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	16.80	9.44	4.37	1.84	0.92	0.46	0.69
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	10.54	5.27	10.54	5.27	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	14.61	10.38	3.46	0.38	0.77	0.00	0.38
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	17.93	8.80	1.96	0.98	0.00	0.33	0.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	8.69	4.01	2.68	1.34	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	19.26	7.32	6.55	0.77	1.54	0.00	0.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	26.02	14.38	9.59	1.71	1.37	1.03	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	24.85	7.45	2.48	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	18.87	8.49	7.08	1.42	1.42	0.00	0.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	16.29	5.43	1.21	0.60	0.60	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	17.29	7.12	5.60	1.02	0.00	0.51	0.51
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	16.35	7.18	6.78	0.00	0.40	0.40	0.80
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	20.23	8.39	4.93	2.96	1.48	0.00	0.99
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	33.05	25.97	12.98	5.90	0.00	0.00	1.18
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	16.34	14.00	4.08	1.75	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	25.46	15.36	10.97	2.19	0.88	0.44	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	22.89	27.13	9.32	1.70	1.70	0.00	0.85
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	18.50	10.15	2.98	2.39	1.19	0.60	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	10.19	8.73	2.91	0.97	0.49	0.49	0.49
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	11.41	10.27	1.14	0.00	0.00	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	6.24	2.91	1.25	0.42	0.00	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	9.00	10.12	9.00	1.12	1.12	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	11.42	3.17	2.22	0.32	0.32	0.32	0.00
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	6.68	0.84	1.25	0.00	0.00	0.00	0.42
Hep-2 cells mock treated, biol_rep1	11898-125E8	10.44	5.57	2.32	0.58	0.35	0.00	0.12
Hep-2 cells mock treated, biol_rep2	11899-125E9	12.32	4.39	4.90	0.34	0.17	0.17	0.17
Hep-2 cells mock treated, biol_rep3	11900-125F1	10.47	5.23	4.32	0.46	0.46	0.00	0.46
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	12.13	6.45	2.30	0.55	0.44	0.22	0.55
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	12.04	4.94	2.15	0.21	0.43	0.00	0.21
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	9.47	4.52	3.66	0.86	0.65	0.22	0.43
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	7.85	6.35	2.99	0.50	0.50	0.00	0.12
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	6.52	4.12	3.09	0.34	0.51	0.00	0.51
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	7.69	3.52	2.88	0.64	0.32	0.00	0.96
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	9.51	6.72	11.19	1.12	0.00	0.56	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	10.82	8.22	9.52	0.87	0.87	0.43	0.43
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	5.29	5.29	13.22	0.00	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	17.28	6.35	4.59	0.35	0.35	0.71	0.00
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	9.44	5.09	1.45	0.00	0.73	0.73	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	6.82	3.32	5.25	0.17	0.70	0.35	0.17
Hepatocyte, donor1	11523-119I2	10.90	8.47	4.84	1.21	1.21	0.00	1.21
Hepatocyte, donor2	11603-120I1	19.39	9.70	3.23	0.00	0.00	0.00	1.08
Hepatocyte, donor3	11684-122I1	12.27	4.29	6.75	1.23	0.61	0.00	0.61
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	30.68	15.66	22.84	1.31	1.96	0.65	0.65
Intestinal epithelial cells (polarized), donor1	11246-116E4	46.67	18.53	13.63	3.85	0.35	1.40	1.40
Iris Pigment Epithelial Cells, donor1	11530-119I9	15.50	2.88	2.47	0.00	0.14	0.00	0.27
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	28.66	19.10	15.92	0.00	0.00	3.18	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	20.03	13.35	26.70	0.00	0.00	0.00	6.68
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	27.08	27.08	27.08	0.00	27.08	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	18.00	19.38	9.69	2.77	4.15	1.38	4.15
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	15.02	15.02	27.53	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	47.47	0.00	11.87	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	7.69	35.88	33.32	0.00	7.69	2.56	2.56
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	13.71	4.57	9.14	0.00	4.57	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	24.36	32.49	30.86	1.62	1.62	0.00	1.62
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	16.67	23.34	31.68	1.67	1.67	3.33	1.67
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	29.04	14.52	21.78	0.00	0.00	0.00	7.26
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	23.82	37.06	26.47	0.00	3.97	1.32	5.29
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	5.54	25.50	17.74	0.00	3.33	2.22	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	20.95	15.71	52.38	0.00	0.00	5.24	10.48
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	11.97	24.56	22.68	1.89	3.15	0.63	1.26
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	12.37	18.56	15.47	3.09	3.09	3.09	1.55
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	43.90	14.63	29.27	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	18.74	23.90	19.38	3.23	2.58	0.00	3.23
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	28.98	28.98	19.32	1.61	4.83	3.22	3.22
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	35.84	23.90	47.79	0.00	11.95	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	21.19	28.52	19.56	3.26	4.07	0.81	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	22.67	28.55	20.99	1.26	0.84	1.26	2.10
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	0.00	0.00	14.37	0.00	0.00	14.37	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	18.48	12.06	12.86	5.63	0.80	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	19.39	12.93	7.39	1.85	1.85	1.85	0.92
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	0.00	15.08	15.08	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	12.75	11.33	6.14	0.47	0.47	0.47	0.47
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	6.35	21.77	15.42	0.91	0.00	0.91	2.72
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	29.48	29.48	29.48	0.00	14.74	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	19.37	13.99	15.07	0.00	3.23	2.15	1.08
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	19.06	19.06	13.98	1.27	1.27	0.00	1.27
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	16.43	16.43	16.43	0.00	16.43	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	12.12	19.77	12.75	0.64	2.55	0.00	2.55
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	18.23	12.76	16.40	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	0.00	31.61	31.61	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	17.14	14.28	19.99	0.71	0.00	1.43	2.86
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	16.59	9.95	13.27	0.00	0.00	3.32	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	20.85	0.00	20.85	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	12.35	8.33	12.66	0.93	2.47	0.00	1.85
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	15.80	26.34	17.56	1.76	1.76	1.76	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	6.29	18.86	31.43	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	12.52	22.25	21.56	0.70	2.09	0.70	0.70
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	33.20	8.85	19.92	0.00	2.21	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	22.69	9.73	12.97	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	19.18	6.10	6.98	1.74	0.87	0.87	0.87
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	20.25	13.50	9.00	0.00	2.25	0.00	2.25
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	27.88	6.97	31.36	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	21.34	4.27	12.80	0.00	1.07	0.00	1.07
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	18.01	15.24	11.08	1.39	4.16	1.39	5.54
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	11.40	22.80	25.65	5.70	2.85	0.00	2.85
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	17.49	17.49	14.73	0.92	0.00	2.76	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	15.13	3.03	9.08	0.00	0.00	0.00	6.05
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	24.83	6.21	12.42	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	11.63	1.06	9.52	1.06	1.06	1.06	0.00
Keratinocyte - epidermal, donor1	11272-116H3	17.14	7.51	3.59	0.82	0.41	0.65	0.24
Keratinocyte - epidermal, donor2	11349-117G8	8.78	4.10	4.10	0.00	0.00	1.17	0.00
Keratinocyte - epidermal, donor3	11421-118F8	13.25	3.79	2.65	0.28	0.19	0.09	0.38
Keratinocyte - oral, donor1	11251-116E9	25.31	6.92	7.15	1.59	0.79	0.34	0.45
Keratocytes, donor1	11527-119I6	27.85	3.09	2.06	0.00	0.69	0.69	0.34
Keratocytes, donor2	11607-120I5	8.20	9.37	4.69	0.00	0.00	0.00	0.00
Keratocytes, donor3	11688-122I5	13.04	0.59	2.17	0.00	0.00	0.20	0.00
Krukenberg tumor cell line:HSKTC	10687-109F3	4.40	13.19	13.19	0.00	13.19	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	14.02	5.39	7.55	2.16	1.08	0.00	0.00
Lens Epithelial Cells, donor2	11609-120I7	24.10	2.31	3.34	0.00	0.12	0.00	0.12
Lens Epithelial Cells, donor3	11690-122I7	14.33	3.03	3.03	0.71	0.30	0.20	0.10
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	11.98	7.71	10.55	0.36	0.71	0.95	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	10.88	3.07	4.47	0.00	0.00	0.28	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	11.65	10.07	8.03	0.31	0.94	1.10	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	7.53	10.75	5.38	0.00	0.00	0.54	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	7.56	7.88	5.36	0.32	0.63	0.63	0.63
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	9.60	6.04	6.47	0.32	0.11	0.22	0.11
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	6.57	6.98	4.51	0.41	0.00	0.00	0.41
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	7.58	4.30	6.83	0.00	0.25	0.76	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	6.62	8.16	7.32	0.28	0.14	0.84	0.42
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	10.68	7.52	5.14	0.00	0.00	0.40	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	9.50	3.68	4.85	0.58	0.19	0.19	0.58
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	8.89	6.48	5.55	0.19	0.37	0.74	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	5.23	2.44	3.83	0.70	0.00	0.00	0.35
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	12.16	2.39	4.05	0.48	0.48	0.72	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	8.93	6.87	5.63	0.27	0.41	0.96	0.55
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	9.24	4.00	8.93	0.00	0.31	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	7.17	2.81	2.81	0.62	0.00	0.62	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	8.97	8.78	10.98	0.18	0.37	1.10	0.37
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	5.59	6.91	5.27	0.33	0.00	0.33	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	6.44	6.15	5.56	0.00	0.00	0.59	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	6.72	7.47	8.96	0.50	0.50	1.24	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	6.30	5.33	6.30	0.48	0.00	0.97	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	8.62	4.31	6.46	0.27	0.27	2.15	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	9.08	7.72	10.90	0.15	0.30	0.00	0.15
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	8.29	7.78	8.81	0.52	0.52	0.52	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	10.05	6.70	2.30	0.00	0.42	1.47	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	7.82	5.71	6.62	0.30	0.15	1.05	0.30
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	13.07	7.57	8.25	0.69	0.69	1.38	0.69
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	10.16	4.89	5.27	0.19	0.19	0.19	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	8.91	9.22	7.95	0.21	0.32	0.32	0.21
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	9.21	3.88	6.30	0.48	0.00	0.97	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	9.26	3.31	4.30	0.00	0.33	0.33	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	10.16	7.06	6.69	0.12	0.50	0.74	0.25
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	11.85	10.74	4.07	0.37	0.74	1.48	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	6.18	4.45	5.19	0.25	0.25	1.24	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	7.70	7.42	5.77	0.41	0.27	1.10	0.27
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	12.87	7.72	5.47	0.64	0.64	0.64	0.32
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	9.74	3.96	4.87	0.30	0.61	0.91	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	9.24	8.82	5.60	0.14	0.42	0.56	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	6.04	6.40	7.47	0.71	0.36	1.07	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	6.79	2.91	5.33	0.00	0.48	0.48	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	8.25	8.56	7.31	0.62	0.16	0.31	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	7.52	8.95	5.01	0.00	0.00	1.07	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	9.80	6.86	3.59	0.00	0.00	0.33	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	8.00	6.12	7.53	0.24	0.24	0.24	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	12.00	7.43	10.15	0.62	0.99	1.86	0.12
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	8.45	3.84	2.31	0.00	0.00	0.26	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	6.86	8.06	6.86	0.30	0.00	0.90	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	58.92	43.05	15.86	0.00	0.00	0.00	4.53
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	38.36	32.22	9.21	1.53	3.84	0.77	0.77
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	39.34	23.75	10.39	3.71	0.74	0.00	2.97
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	39.35	46.97	20.31	6.35	3.39	0.42	2.54
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	40.09	24.62	9.85	3.52	2.81	0.00	1.41
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	35.49	20.55	10.27	0.00	0.00	0.00	2.80
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	28.34	37.10	22.16	3.09	1.55	0.00	2.06
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	35.68	16.65	10.71	1.19	2.38	0.00	5.95
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	47.95	29.18	9.27	3.62	2.04	0.23	1.13
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	29.08	32.57	11.92	2.04	1.16	0.29	1.16
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	36.01	23.41	10.80	3.60	0.45	0.45	1.35
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	63.00	36.85	13.96	2.71	3.12	0.54	2.44
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	31.32	41.60	17.46	1.54	5.14	0.00	1.03
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	31.76	19.41	8.12	1.06	2.12	0.00	0.35
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	31.98	21.32	7.33	2.00	0.67	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	31.07	48.90	21.90	4.58	3.57	1.02	1.53
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	38.95	32.02	11.74	2.67	1.33	0.53	1.87
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	40.06	28.72	15.30	2.65	1.70	0.57	1.32
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	42.95	51.54	15.34	2.45	4.91	0.00	3.07
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	38.32	39.96	20.39	1.63	1.63	0.00	0.82
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	38.32	31.65	11.66	2.71	2.08	0.62	1.87
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	30.83	36.71	17.10	5.04	2.80	0.00	1.12
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	52.55	46.37	8.24	5.15	2.06	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	40.64	31.35	11.03	2.61	2.90	0.29	0.87
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	30.19	24.81	11.06	2.39	1.79	0.00	0.30
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	47.58	21.02	8.85	0.55	1.11	0.55	1.11
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	44.54	39.24	14.49	2.47	3.18	0.00	3.18
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	35.77	35.03	12.91	2.58	3.69	0.74	3.32
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	44.90	23.03	14.97	2.30	0.00	0.00	1.15
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	55.26	38.38	11.51	2.69	2.69	0.38	1.92
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	36.80	34.53	8.49	2.83	3.96	0.57	0.57
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	38.56	20.51	12.31	3.28	2.46	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	53.77	32.54	12.20	3.62	3.16	0.45	3.62
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	43.81	34.47	12.93	2.15	2.15	0.00	1.44
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	52.28	20.17	6.72	2.24	1.49	0.00	1.49
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	53.51	36.04	12.63	1.49	2.97	0.00	1.11
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	41.78	24.12	8.18	2.15	2.58	0.43	1.29
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	54.80	27.40	15.41	1.71	0.86	0.86	1.71
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	47.98	28.65	10.66	1.67	3.33	0.33	1.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	45.25	41.02	10.86	5.43	3.62	0.60	1.81
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	47.64	20.62	8.53	0.71	2.13	0.00	2.13
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	46.06	32.31	7.22	4.12	2.75	0.34	1.37
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	42.40	33.28	17.71	8.59	1.07	0.54	1.07
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	45.79	30.30	7.41	1.35	2.02	0.00	1.35
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	51.86	31.11	7.41	3.70	2.96	1.11	1.11
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	53.49	32.56	10.47	3.49	1.16	0.00	1.16
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	51.83	23.27	6.35	0.00	5.29	0.00	1.06
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	48.82	28.81	7.60	3.20	3.20	0.00	1.60
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	38.52	53.79	22.53	5.09	1.45	0.00	3.63
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	45.99	32.96	13.03	5.37	3.07	0.00	1.53
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	45.38	41.93	16.77	7.89	3.95	0.99	3.45
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	38.58	39.52	20.70	6.59	2.82	0.94	1.88
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	43.75	38.72	11.06	4.53	2.51	0.00	2.01
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	45.06	36.95	13.97	3.15	1.80	0.90	4.96
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	22.37	56.80	17.21	1.72	5.16	1.72	5.16
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	51.66	35.63	14.70	4.01	3.12	0.00	2.67
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	48.10	48.88	17.99	3.91	2.74	0.39	1.17
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	30.35	54.76	17.15	3.96	1.32	0.00	0.66
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	43.59	50.34	20.24	4.67	2.59	0.52	1.56
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	55.57	48.57	17.94	4.81	3.06	0.88	2.19
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	24.04	40.26	21.25	2.80	7.27	0.00	1.68
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	42.40	37.10	17.22	3.09	3.97	0.00	2.65
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	51.30	43.97	18.90	5.01	4.24	0.00	2.31
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	37.47	42.03	17.72	2.53	3.54	0.00	2.03
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	46.14	30.76	11.05	2.88	1.92	0.48	1.92
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	38.96	35.78	14.31	3.98	1.19	0.00	1.99
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	34.63	48.61	14.58	3.04	3.65	1.22	1.22
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	17.98	37.35	8.30	0.69	2.08	0.69	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	43.32	36.86	13.68	3.80	2.66	0.38	1.52
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	33.05	42.86	16.01	5.68	2.58	1.03	2.07
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	38.09	38.09	13.30	1.21	1.21	1.21	1.81
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	42.78	32.01	19.96	3.80	4.44	0.00	2.22
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	41.58	47.44	10.66	2.67	4.80	0.53	2.67
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	28.16	31.03	17.81	0.00	3.45	1.15	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	49.37	41.14	22.11	2.06	3.09	1.54	1.54
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	53.76	50.93	12.03	4.24	1.41	0.00	0.71
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	38.02	31.21	10.21	2.27	2.27	0.00	1.13
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	46.59	33.70	15.39	2.08	2.50	0.42	1.25
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	35.24	36.02	9.40	3.92	2.35	0.78	3.13
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	32.15	27.98	6.26	0.84	1.67	0.42	2.09
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	49.72	30.67	9.76	2.79	3.25	0.00	1.39
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	32.11	37.47	10.04	2.68	0.67	0.00	1.34
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	44.91	36.36	8.55	3.21	2.14	0.00	0.53
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	61.42	32.33	8.08	1.21	3.23	0.40	1.62
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	44.05	42.22	9.18	0.92	0.00	0.00	4.59
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	35.56	34.68	9.78	3.56	3.56	0.00	1.78
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	65.53	28.49	10.83	3.99	3.42	0.00	1.14
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	55.22	34.51	13.04	3.07	2.30	0.00	2.30
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	47.06	33.38	9.85	2.74	1.64	0.00	1.09
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	57.91	33.85	9.80	3.56	1.34	0.45	2.23
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	93.58	33.53	9.88	3.38	3.64	0.26	1.30
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	53.05	29.84	14.59	1.99	2.65	0.00	1.99
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	76.91	41.57	16.63	0.00	2.08	0.00	2.08
Macrophage - monocyte derived, donor1	11232-116C8	28.03	3.87	3.65	0.23	0.00	0.46	0.23
Macrophage - monocyte derived, donor2	11313-117C8	14.13	8.44	2.75	1.28	1.10	0.00	0.37
Macrophage - monocyte derived, donor3	11389-118C3	22.94	6.55	3.54	0.52	0.13	0.00	0.13
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	6.37	3.19	1.06	0.00	1.06	0.53	0.00
Mallassez-derived cells, donor2	11929-125I3	11.41	4.75	3.96	0.79	0.48	0.48	0.16
Mallassez-derived cells, donor3	11930-125I4	9.03	4.86	5.28	0.28	0.69	1.11	0.28
Mammary Epithelial Cell, donor1	11273-116H4	20.23	5.28	3.39	0.80	0.60	0.00	0.10
Mammary Epithelial Cell, donor2	11350-117G9	17.66	7.53	1.74	0.00	0.29	0.58	0.58
Mammary Epithelial Cell, donor3	11422-118F9	14.47	4.24	4.24	0.00	0.25	0.00	0.00
Mast cell - stimulated, donor1	11487-119E2	4.75	9.49	12.20	0.00	0.00	2.71	2.71
Mast cell, donor1	11563-120D6	28.55	24.12	19.57	2.27	1.30	1.51	1.30
Mast cell, donor2	11565-120D8	45.47	67.46	89.15	23.77	11.00	13.37	6.54
Mast cell, donor3	11566-120D9	41.42	54.71	74.97	11.48	11.93	8.78	6.75
Mast cell, donor4	11567-120E1	35.28	57.26	75.88	10.11	8.33	8.51	4.79
Mast cell, expanded and stimulated, donor5	11940-126A5	25.06	13.75	22.51	0.89	1.00	2.33	0.78
Mast cell, expanded and stimulated, donor8	11942-126A7	14.01	13.42	20.43	1.17	2.33	2.33	1.17
Mast cell, expanded, donor5	11939-126A4	27.30	20.08	19.62	1.84	1.15	1.61	0.80
Mast cell, expanded, donor8	11941-126A6	42.18	12.55	10.04	0.67	1.00	1.51	0.33
Melanocyte - dark, donor1	11502-119F8	8.06	4.58	3.88	0.20	0.10	0.20	0.20
Melanocyte - dark, donor2	11582-120F7	7.61	4.85	2.08	0.35	0.69	0.00	0.00
Melanocyte - dark, donor3	11663-122F7	14.63	1.52	2.68	0.14	0.14	0.14	0.14
Melanocyte - light, donor1	11274-116H5	11.99	1.88	4.00	0.71	0.00	0.00	0.24
Melanocyte - light, donor2	11351-117H1	12.28	2.05	4.09	0.00	0.68	0.00	0.00
Melanocyte - light, donor3	11423-118G1	7.81	0.87	5.20	0.00	0.00	1.73	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	9.16	1.15	3.02	0.00	0.31	0.31	0.31
Melanocyte, donor2 (MC+2)	12739-135I3	8.34	2.15	1.88	0.54	0.54	0.00	0.00
Melanocyte, donor3 (MC+3)	12837-137B2	11.52	2.14	4.02	0.27	0.00	0.00	0.00
Meningeal Cells, donor1	11493-119E8	18.11	10.79	9.55	0.74	0.74	0.74	0.12
Meningeal Cells, donor2	11573-120E7	21.13	3.96	3.08	0.00	0.00	0.88	0.00
Meningeal Cells, donor3	11654-122E7	15.65	5.13	4.97	0.82	0.33	0.65	0.33
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	11.12	3.14	2.85	0.29	0.00	0.29	0.00
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	12.18	9.26	4.13	0.40	0.50	0.60	0.70
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	13.14	2.63	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	9.16	0.00	0.00	0.00	0.00	1.31	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	6.46	5.02	5.74	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	14.40	6.99	2.75	0.42	0.21	0.00	0.64
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	12.06	4.52	1.01	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	14.28	4.61	5.27	0.88	0.66	0.44	0.22
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	7.31	8.04	4.38	2.19	0.00	1.46	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	12.28	4.71	6.55	0.61	1.23	0.41	0.20
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	13.99	1.25	2.49	0.14	0.14	0.14	0.00
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	11.15	2.60	0.74	0.37	0.37	0.37	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	23.42	0.92	0.92	0.13	0.13	0.13	0.13
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	12.46	0.59	0.59	0.00	0.00	0.30	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	7.01	2.34	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	12.81	1.92	2.56	0.64	0.00	0.00	0.64
Mesenchymal stem cells - adipose, donor0	11217-116B2	6.38	4.25	3.90	0.00	0.35	0.71	0.35
Mesenchymal stem cells - hepatic, donor0	11218-116B3	24.71	1.25	0.63	0.00	0.00	0.00	0.63
Mesenchymal stem cells - umbilical, donor0	11214-116A8	10.16	1.45	4.35	0.73	0.00	0.00	0.00
Mesothelial Cells, donor1	11247-116E5	18.56	9.02	3.98	2.12	0.00	0.27	0.27
Mesothelial Cells, donor2	12156-128G5	8.01	9.51	2.50	1.00	0.50	0.50	0.00
Mesothelial Cells, donor3	11402-118D7	12.57	8.31	3.76	1.16	0.58	0.22	0.29
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	10.80	22.96	5.40	2.70	1.35	0.00	1.35
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	15.52	8.13	6.40	0.74	1.97	0.74	0.74
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	17.08	9.13	3.24	2.36	0.59	0.00	0.88
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	24.20	3.46	0.00	6.91	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	11.16	6.20	2.48	0.62	0.00	0.00	0.31
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	9.33	11.20	3.11	1.04	0.41	0.41	0.21
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	13.90	2.32	2.32	0.00	2.32	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	17.77	8.51	3.50	0.25	0.50	0.75	0.75
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	16.29	9.78	4.19	0.47	0.93	0.00	0.47
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	0.00	19.47	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	11.99	5.08	1.83	0.20	1.02	0.00	0.41
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	9.50	6.73	1.98	0.00	0.40	0.00	0.40
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	11.50	4.42	4.42	0.88	0.00	0.00	0.88
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	8.36	6.08	2.28	0.76	0.38	0.00	0.38
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	10.53	1.32	0.00	0.00	1.32	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	10.40	3.61	0.85	0.00	0.42	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	6.45	4.60	1.84	0.92	1.84	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	8.05	3.28	0.60	0.60	0.00	0.30	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	5.03	3.35	1.68	1.68	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	5.52	2.26	0.50	0.25	0.25	0.00	0.25
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	7.84	4.52	0.71	1.19	0.24	0.00	0.48
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	5.53	0.55	0.55	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	4.37	3.45	0.69	0.00	0.23	0.23	0.46
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	6.73	4.84	1.68	0.84	0.00	0.21	0.21
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	9.58	2.65	0.61	0.61	0.00	0.00	0.20
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	6.65	3.43	1.50	0.86	0.21	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	5.78	4.89	0.89	1.56	0.22	0.00	0.22
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	10.32	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	8.76	2.19	0.88	1.10	0.22	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	6.08	9.13	1.52	1.01	0.00	0.51	0.51
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	8.28	3.31	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	8.70	2.17	1.09	0.54	0.00	0.27	0.27
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	9.41	4.41	2.35	0.59	0.29	0.29	0.29
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	8.72	1.09	0.00	0.00	0.00	0.00	1.09
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	20.66	1.92	1.44	0.48	0.48	0.48	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	12.81	4.80	1.20	1.20	0.40	0.40	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	5.48	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	19.02	1.50	2.00	0.50	0.00	0.00	0.50
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	80.84	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	8.15	2.04	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	24.52	2.19	1.75	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	3.31	0.00	3.31	1.10	0.00	0.00	1.10
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	16.01	0.64	0.64	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	20.08	2.98	1.49	0.25	0.00	0.00	0.25
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	7.65	0.70	2.09	0.70	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	13.26	0.00	2.21	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	22.56	4.10	1.37	0.00	0.00	0.00	0.68
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	11.82	2.19	2.63	1.75	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	17.75	4.26	1.07	0.36	1.07	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	21.04	5.05	1.68	0.56	0.00	0.28	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	9.14	2.49	3.74	0.42	0.42	0.42	0.42
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	6.41	5.24	0.58	0.00	0.58	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	22.32	4.83	1.51	0.30	0.00	0.00	0.60
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	13.36	7.10	2.09	1.67	0.42	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	21.66	7.22	0.00	0.00	0.00	7.22	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	21.24	4.62	0.00	0.92	0.92	0.92	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	19.35	5.12	3.41	0.57	0.57	0.00	1.14
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	15.20	5.94	2.49	0.55	0.41	0.14	0.28
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	17.62	6.74	2.59	1.81	0.26	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	12.44	3.86	1.72	0.86	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	19.69	2.54	0.64	0.64	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	19.48	4.27	4.00	0.80	0.27	0.53	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	22.75	7.78	5.09	1.20	0.90	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	15.82	4.10	3.81	0.42	0.14	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	20.70	3.82	2.23	0.00	0.32	0.32	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	21.67	6.86	4.20	0.44	0.22	0.00	0.88
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	18.20	3.03	1.90	0.38	0.38	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	20.46	3.98	2.56	0.85	0.28	0.57	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	17.21	8.36	2.46	0.49	0.49	0.25	0.25
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	13.69	5.21	2.61	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	21.46	3.82	3.82	1.76	0.59	0.59	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	20.76	10.96	4.04	0.58	0.86	0.29	0.58
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	28.44	11.95	4.95	1.24	0.82	0.41	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	25.01	7.44	5.36	0.89	0.00	0.60	0.89
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	7.53	0.00	0.00	0.00	0.00	3.77	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	5.35	8.91	3.56	0.00	1.78	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	13.14	6.57	2.96	0.00	0.66	0.66	0.33
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	12.62	5.26	1.05	3.16	1.05	0.00	1.05
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	18.98	5.54	3.76	0.00	0.40	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	17.70	1.86	3.73	0.00	0.00	0.00	0.93
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	12.02	2.25	3.00	0.75	0.00	0.00	0.38
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	13.05	5.06	2.66	0.00	0.53	0.27	0.27
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	16.29	5.54	2.60	0.23	0.11	0.23	0.23
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	8.10	9.58	4.42	1.47	0.74	0.74	1.47
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	15.02	5.50	3.30	0.37	0.37	0.73	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	12.44	9.33	6.22	0.00	0.00	0.00	1.56
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	13.36	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	3.86	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	6.06	6.06	2.02	2.02	1.01	0.00	1.01
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	7.59	3.79	0.84	0.00	0.42	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	8.17	24.51	5.45	2.72	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	1.91	4.45	0.00	0.64	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	4.05	4.05	0.81	1.62	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	3.02	10.57	0.00	12.08	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	22.84	91.36	17.13	45.68	11.42	0.00	5.71
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	19.57	97.87	9.79	13.05	0.00	3.26	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	14.26	28.51	9.50	9.50	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	75.29	37.65	0.00	12.55	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	12.93	2.80	2.37	0.22	0.00	0.00	0.22
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	15.68	2.61	2.61	0.52	0.52	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	5.34	2.67	2.67	0.00	0.00	0.67	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	3.34	3.34	1.67	0.42	0.00	0.00	0.42
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	8.56	5.32	3.80	0.19	0.38	0.19	0.76
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	6.38	17.55	15.96	1.60	0.00	0.00	1.60
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	1.36	3.40	4.08	0.68	0.00	0.00	0.68
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	20.21	3.68	1.84	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	4.19	2.51	2.09	0.84	0.84	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	5.35	2.32	1.86	0.00	0.46	0.46	0.23
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	5.13	2.70	2.97	0.54	0.54	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	11.98	4.84	4.20	0.63	0.42	0.21	0.00
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	22.27	11.13	11.13	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	4.96	2.98	0.99	0.00	0.00	0.99	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	10.29	2.44	1.08	0.54	0.00	0.00	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	4.76	1.81	1.59	0.00	0.23	0.23	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	5.39	2.61	1.63	0.00	0.16	0.00	0.16
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	14.03	4.01	2.92	0.00	0.73	0.36	0.36
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	4.77	4.24	4.77	0.00	0.53	0.00	0.53
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	6.00	2.40	2.40	0.00	0.00	0.60	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	9.19	5.25	0.66	0.33	0.00	0.00	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	4.07	1.46	1.46	0.00	0.33	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	9.35	6.17	4.06	0.53	0.53	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	7.03	4.22	2.11	0.00	0.70	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	5.06	3.68	2.30	0.00	0.46	0.46	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	9.00	3.53	2.25	0.00	1.29	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	9.66	2.76	2.07	1.03	0.34	0.00	0.34
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	22.76	2.53	0.00	0.00	2.53	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	9.13	6.68	3.79	0.22	0.67	0.00	0.67
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	4.66	6.77	4.66	0.42	0.42	0.42	0.42
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	6.65	4.51	1.19	0.24	0.95	0.24	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	7.73	5.58	3.00	0.00	0.00	0.00	0.86
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	36.11	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	6.00	4.00	2.33	0.33	0.00	0.00	0.33
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	8.12	7.21	6.76	0.90	1.35	0.00	0.45
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	4.36	3.57	1.59	0.00	0.40	0.40	0.00
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	3.71	5.57	0.93	0.00	1.86	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	9.08	4.92	3.41	0.00	0.00	0.38	0.38
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	5.54	3.58	1.63	0.33	0.00	0.00	0.33
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	4.36	3.05	2.61	0.44	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	7.24	11.31	3.17	0.45	0.45	0.45	0.90
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	4.41	0.00	2.65	0.88	0.88	0.00	0.88
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	3.99	2.66	2.66	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	9.42	4.96	2.48	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	8.04	4.21	2.30	0.00	0.00	0.00	0.38
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	12.70	4.84	4.84	0.00	0.30	0.00	0.60
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	10.83	3.76	2.65	0.22	0.44	0.00	0.22
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	3.39	2.71	2.03	0.00	1.36	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	30.66	10.22	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	5.49	4.88	0.61	0.00	0.61	0.00	0.61
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	5.35	3.78	3.15	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	3.93	3.03	2.42	0.00	0.00	0.00	0.61
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	2.37	2.37	3.96	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	7.94	5.67	3.40	0.00	1.13	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	45.52	0.00	15.17	0.00	0.00	0.00	0.00
Myoblast, donor1	11241-116D8	12.92	4.22	2.73	0.37	0.75	0.12	0.25
Myoblast, donor2	11322-117D8	17.64	6.33	4.03	0.58	0.77	0.38	0.19
Myoblast, donor3	11398-118D3	12.44	5.55	3.53	0.17	0.50	0.17	0.00
NK T cell leukemia cell line:KHYG-1	10777-110G3	15.76	14.74	12.11	0.15	1.02	0.73	0.29
Natural Killer Cells, donor1	11230-116C6	55.97	84.87	148.84	9.23	13.53	29.52	7.07
Natural Killer Cells, donor2	11311-117C6	38.90	98.01	181.54	8.75	16.89	25.03	7.84
Natural Killer Cells, donor3	11387-118C1	46.57	87.06	121.29	8.47	11.23	20.25	5.34
Neural stem cells, donor1	11275-116H6	31.21	22.14	13.43	2.90	0.36	1.45	0.73
Neural stem cells, donor2	11352-117H2	23.11	3.85	5.78	1.93	0.00	3.85	0.00
Neurons, donor1	11494-119E9	17.07	7.97	21.62	1.14	0.00	0.00	0.00
Neurons, donor2	11574-120E8	22.02	4.18	9.47	0.44	0.44	0.66	0.00
Neurons, donor3	11655-122E8	21.38	9.04	15.62	0.00	3.29	2.47	0.82
Neutrophils, donor1	11233-116C9	211.59	10.21	8.35	0.00	0.00	0.93	0.00
Neutrophils, donor2	11314-117C9	136.25	11.60	8.70	0.00	0.00	0.00	0.00
Neutrophils, donor3	11390-118C4	247.39	7.33	13.44	1.22	1.22	2.44	2.44
Nucleus Pulposus Cell, donor1	11252-116F1	22.80	1.66	1.78	0.00	0.36	0.00	0.00
Nucleus Pulposus Cell, donor2	11409-118E5	11.07	0.98	0.00	0.00	0.00	0.33	0.00
Nucleus Pulposus Cell, donor3	11462-119B4	7.02	3.01	2.21	0.40	0.00	0.00	0.20
Olfactory epithelial cells, donor1	11933-125I7	13.21	5.64	2.89	0.41	0.69	0.28	0.00
Olfactory epithelial cells, donor2	11934-125I8	14.19	4.78	3.62	0.29	1.30	0.29	0.72
Olfactory epithelial cells, donor3	11935-125I9	11.01	2.61	2.04	0.11	0.11	0.00	0.11
Olfactory epithelial cells, donor4	11936-126A1	20.65	3.51	3.12	0.39	0.68	0.29	0.00
Oligodendrocyte - precursors, donor1	11496-119F2	16.85	4.21	3.01	1.20	0.00	0.00	0.00
Osteoblast - differentiated, donor1	11276-116H7	12.97	4.89	1.91	0.21	0.21	0.00	0.43
Osteoblast - differentiated, donor2	11353-117H3	6.86	2.29	3.43	0.00	0.00	0.00	0.00
Osteoblast - differentiated, donor3	11425-118G3	11.17	1.86	0.62	1.24	0.62	0.00	0.62
Osteoblast, donor1	11277-116H8	12.51	10.55	5.67	0.59	0.39	0.78	0.59
Osteoblast, donor2	11354-117H4	25.99	9.13	2.81	0.00	0.70	0.70	0.00
Osteoblast, donor3	11426-118G4	20.79	8.89	3.91	0.53	0.89	0.18	0.00
Pancreatic stromal cells, donor1	11249-116E7	18.36	4.38	2.86	0.34	0.34	0.17	0.08
Pericytes, donor1	11491-119E6	14.46	1.34	0.89	0.00	0.00	0.00	0.11
Pericytes, donor2	11571-120E5	10.64	2.04	2.26	0.68	0.00	0.00	0.45
Pericytes, donor3	11652-122E5	18.72	3.05	0.81	0.20	0.41	0.41	0.00
Perineurial Cells, donor1	11499-119F5	21.02	1.92	2.49	0.23	0.11	0.23	0.00
Perineurial Cells, donor2	11579-120F4	13.89	4.88	2.02	0.37	0.64	0.00	0.28
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	61.20	25.18	73.63	3.51	3.51	7.01	3.19
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	52.65	28.16	53.38	2.20	6.61	5.39	2.94
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	47.11	27.82	45.17	1.94	4.53	6.99	1.55
Placental Epithelial Cells, donor1	11278-116H9	17.94	10.28	2.15	1.20	0.24	0.24	0.48
Placental Epithelial Cells, donor2	11355-117H5	7.76	5.54	3.33	0.00	0.00	1.11	0.00
Placental Epithelial Cells, donor3	11427-118G5	13.94	7.85	2.55	0.98	0.20	0.00	0.59
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	5.38	1.90	0.95	0.00	0.00	0.00	0.32
Preadipocyte - breast, donor1	11467-119B9	16.32	3.19	2.81	0.00	0.00	0.00	0.19
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	22.19	5.09	4.57	0.78	0.39	0.52	0.39
Preadipocyte - breast, donor2	11328-117E5	13.73	2.48	1.35	0.23	0.00	0.00	0.00
Preadipocyte - omental, donor1	11468-119C1	16.20	2.56	2.45	0.00	0.11	0.21	0.43
Preadipocyte - omental, donor2	11329-117E6	15.71	5.67	0.87	0.00	0.44	0.44	0.00
Preadipocyte - omental, donor3	11403-118D8	15.90	5.30	3.44	0.29	0.86	0.14	0.43
Preadipocyte - perirenal, donor1	11469-119C2	8.86	1.97	0.98	0.00	0.00	0.00	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	10.13	12.59	4.30	0.92	1.23	0.92	1.23
Preadipocyte - subcutaneous, donor2	11356-117H6	9.03	10.98	4.07	0.89	0.53	0.00	0.53
Preadipocyte - subcutaneous, donor3	11428-118G6	10.22	5.45	3.24	0.51	1.19	0.17	0.17
Preadipocyte - visceral, donor1	11280-116I2	13.13	10.62	4.47	0.84	0.47	0.28	0.75
Preadipocyte - visceral, donor2	11357-117H7	4.14	8.28	4.60	0.46	0.46	0.00	0.46
Preadipocyte - visceral, donor3	11429-118G7	6.69	7.11	2.93	0.42	0.52	0.31	0.31
Prostate Epithelial Cells (polarized), donor1	11253-116F2	40.73	13.43	12.97	1.96	0.91	1.21	0.15
Prostate Epithelial Cells, donor2	11331-117E8	12.86	5.01	3.11	0.54	0.41	0.00	0.41
Prostate Epithelial Cells, donor3	11404-118D9	17.33	3.37	1.16	0.12	0.43	0.06	0.31
Prostate Stromal Cells, donor1	11254-116F3	21.64	8.43	3.30	0.91	1.14	0.34	0.23
Prostate Stromal Cells, donor2	11332-117E9	16.14	10.04	2.51	0.36	0.36	0.36	0.00
Prostate Stromal Cells, donor3	11405-118E1	15.95	3.02	1.36	0.52	0.21	0.31	0.31
Renal Cortical Epithelial Cells, donor1	11516-119H4	9.49	6.20	9.12	1.09	0.00	0.36	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	13.31	3.47	3.05	0.69	0.21	0.00	0.35
Renal Epithelial Cells, donor1	11517-119H5	9.13	5.58	6.09	0.51	0.00	0.51	0.00
Renal Epithelial Cells, donor2	11597-120H4	12.09	9.96	8.54	0.71	0.71	0.71	0.00
Renal Epithelial Cells, donor3	11678-122H4	18.10	3.07	3.71	1.06	0.53	0.11	0.64
Renal Glomerular Endothelial Cells, donor1	11514-119H2	6.81	14.30	3.40	0.68	0.68	0.68	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	7.95	11.05	7.55	0.81	0.81	0.40	0.13
Renal Glomerular Endothelial Cells, donor3	11675-122H1	8.21	7.33	6.66	0.00	0.89	0.00	0.22
Renal Glomerular Endothelial Cells, donor4	11783-124B1	5.32	5.99	6.65	0.00	0.00	1.33	0.00
Renal Mesangial Cells, donor1	11518-119H6	18.05	5.28	3.74	0.66	0.22	0.00	0.22
Renal Mesangial Cells, donor2	11598-120H5	10.03	5.64	5.02	0.00	0.00	0.00	0.00
Renal Mesangial Cells, donor3	11679-122H5	8.60	4.99	4.72	0.28	0.55	0.28	0.83
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	13.15	7.25	7.25	2.15	1.07	0.81	0.54
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	8.86	5.06	2.95	0.00	0.42	0.84	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	13.31	5.98	6.36	1.16	0.58	0.00	0.00
Retinal Pigment Epithelial Cells, donor0	11215-116A9	12.70	1.81	3.11	0.78	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor1	11528-119I7	9.66	6.25	5.97	0.85	0.57	0.00	0.57
Retinal Pigment Epithelial Cells, donor2	11608-120I6	6.17	5.15	5.15	0.00	2.06	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	4.77	4.01	2.51	0.00	0.75	0.50	0.25
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	31.67	12.70	5.61	2.41	0.67	0.13	0.53
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	21.44	8.93	5.36	0.00	1.79	0.00	0.89
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	25.87	6.60	2.20	0.55	0.00	0.55	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	24.36	11.02	4.64	1.16	0.58	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	19.76	9.10	6.11	0.65	1.04	0.26	0.65
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	22.44	11.12	4.47	1.09	0.79	0.20	0.79
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	38.15	12.49	4.35	1.45	0.45	0.22	0.89
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	26.42	9.06	4.96	0.37	0.74	0.50	0.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	20.63	10.02	3.03	0.58	1.05	0.35	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	31.20	8.55	5.55	0.92	0.00	0.46	0.69
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	17.80	8.21	4.38	1.10	1.23	0.41	0.82
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	23.45	9.68	2.42	0.91	1.21	0.45	0.76
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	38.71	7.53	4.66	0.72	0.36	0.36	0.72
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	21.38	9.32	5.45	1.00	0.72	0.14	0.57
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	21.36	9.12	6.22	0.43	0.32	0.11	0.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	30.31	10.62	3.32	1.55	0.44	0.44	0.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	17.78	11.09	8.03	0.38	0.76	0.38	1.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	23.66	10.34	4.38	0.65	0.37	0.37	0.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	35.89	12.40	10.33	0.38	1.13	0.00	0.94
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	16.99	15.39	7.30	1.06	0.93	0.53	0.80
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	26.18	11.97	5.74	1.27	0.49	0.49	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	32.65	16.04	6.87	0.76	0.95	0.57	0.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	17.30	11.11	9.29	0.53	0.75	0.96	0.32
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	19.06	14.02	9.25	3.64	0.84	0.00	0.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	27.00	16.06	7.69	1.03	1.20	1.03	1.54
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	16.77	12.58	8.20	0.73	1.46	0.55	2.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	23.05	13.73	7.48	1.23	0.74	0.74	0.25
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	30.49	15.04	8.46	1.34	1.21	0.27	0.94
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	19.81	13.68	8.49	0.71	2.59	0.94	0.94
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	22.02	16.27	6.15	0.79	1.19	0.79	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	29.00	17.77	12.39	1.17	0.94	0.94	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	23.64	9.75	8.71	0.83	1.66	1.04	0.62
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	14.16	14.82	7.30	1.33	1.55	1.11	1.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	28.41	13.37	6.68	0.42	0.21	0.84	0.84
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	22.34	10.50	7.27	0.81	0.40	0.54	1.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	24.69	14.13	9.88	0.85	1.70	0.51	0.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	31.23	12.92	6.56	2.70	2.12	0.58	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	19.94	9.80	8.94	0.69	0.69	0.69	0.52
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	29.08	11.52	6.58	0.82	0.96	0.41	0.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	30.37	12.97	5.58	1.15	0.16	0.66	0.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	18.58	9.54	4.94	1.02	0.51	0.85	0.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	22.49	8.43	4.59	0.30	0.59	0.44	0.59
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	26.66	9.60	7.20	0.53	1.60	0.53	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	15.76	6.36	4.98	0.14	1.24	0.28	0.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	26.67	5.00	2.62	0.95	0.48	0.24	0.71
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	35.87	7.05	4.64	1.01	0.40	0.00	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	16.67	4.43	2.64	0.19	0.57	0.38	0.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	20.61	6.29	4.89	0.70	0.00	0.35	0.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	21.15	6.04	3.32	0.91	0.30	0.00	0.91
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	19.70	5.26	3.67	0.24	0.49	0.12	1.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	68.56	10.63	6.99	0.87	0.73	0.73	0.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	30.42	3.65	4.87	0.61	0.00	0.61	0.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	15.07	4.22	2.11	0.30	0.00	0.30	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	28.50	6.56	3.62	0.00	0.90	0.00	0.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	35.94	6.29	4.19	0.30	0.30	0.00	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	20.07	4.49	5.55	0.47	0.83	0.71	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	25.83	6.40	4.27	0.85	0.43	0.00	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	25.84	4.81	3.00	0.00	0.00	0.00	0.00
Schwann Cells, donor1	11498-119F4	4.70	4.70	3.39	0.56	0.75	0.00	0.38
Schwann Cells, donor2	11578-120F3	3.40	3.40	0.00	0.00	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	8.54	3.07	1.75	0.22	0.22	0.22	0.00
Sebocyte, donor1	11220-116B5	24.10	9.31	7.67	3.29	1.10	0.00	0.00
Sebocyte, donor2	11301-117B5	10.57	12.41	4.14	0.46	1.38	0.00	0.00
Sebocyte, donor3	11378-118B1	11.34	5.36	2.06	0.41	0.21	0.00	0.21
Sertoli Cells, donor1	11255-116F4	23.19	4.97	0.00	0.00	1.66	0.00	0.00
Sertoli Cells, donor2	11333-117F1	14.12	2.82	0.00	0.00	0.00	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	18.12	5.37	4.13	0.62	0.18	0.09	0.35
Skeletal Muscle Cells, donor2	11358-117H8	10.84	4.34	1.45	1.45	1.45	0.00	0.00
Skeletal Muscle Cells, donor3	11430-118G8	10.87	8.36	6.69	0.84	0.00	0.00	0.84
Skeletal Muscle Cells, donor4	11451-119A2	7.54	6.28	3.93	0.63	0.47	0.16	0.31
Skeletal Muscle Cells, donor5	11455-119A6	7.58	5.20	4.46	0.59	0.45	0.15	0.15
Skeletal Muscle Cells, donor6	11459-119B1	6.16	8.46	6.00	0.31	0.62	0.31	0.77
Skeletal Muscle Satellite Cells, donor1	11240-116D7	20.03	2.77	3.40	0.38	0.00	0.38	0.25
Skeletal Muscle Satellite Cells, donor2	11321-117D7	11.27	3.00	4.57	0.43	0.14	0.29	0.43
Skeletal Muscle Satellite Cells, donor3	11397-118D2	13.69	8.04	6.05	0.40	0.60	0.10	0.30
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	19.38	8.43	3.62	0.84	0.51	0.08	0.42
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	6.51	7.24	6.51	1.45	0.72	0.00	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	5.50	5.92	4.40	0.14	0.96	0.41	0.41
Skin - palm, donor1	10286-104F7	8.06	26.86	53.72	0.00	2.69	0.00	2.69
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	5.19	3.46	2.88	0.72	0.72	0.14	0.14
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	31.08	37.62	22.90	6.54	0.82	9.00	0.82
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	5.32	3.76	2.60	0.26	0.39	0.78	0.13
Small Airway Epithelial Cells, donor1	11256-116F5	14.73	4.17	1.39	0.14	0.00	0.28	0.14
Small Airway Epithelial Cells, donor2	11334-117F2	11.25	8.86	4.36	0.98	0.28	0.14	0.14
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	58.99	21.78	18.82	2.54	2.75	2.33	1.27
Small Airway Epithelial Cells, donor3	11406-118E2	17.84	2.25	1.65	0.30	0.30	0.00	0.07
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	7.41	2.47	0.00	0.31	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	13.12	3.56	6.67	0.44	0.22	1.11	0.22
Smooth Muscle Cells - Aortic, donor0	11210-116A4	21.16	5.88	5.29	0.59	0.00	1.18	1.76
Smooth Muscle Cells - Aortic, donor1	11283-116I5	28.07	12.60	10.17	1.55	1.77	0.22	1.10
Smooth Muscle Cells - Aortic, donor2	11360-117I1	13.78	9.84	5.91	0.79	0.39	0.39	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	15.45	8.50	4.64	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	9.01	1.00	3.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	16.37	6.39	4.39	0.27	0.27	0.53	0.27
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	12.63	4.21	2.66	0.66	0.22	0.44	0.22
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	8.19	2.82	3.58	0.26	0.26	0.13	0.00
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	18.23	1.95	1.30	0.00	0.00	0.00	0.65
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	12.70	2.07	3.25	0.89	1.48	1.18	0.30
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	10.68	3.42	1.71	0.71	0.28	0.28	0.14
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	8.62	3.90	3.74	0.33	0.33	0.49	0.16
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	10.96	1.22	0.61	0.30	0.30	0.00	0.61
Smooth Muscle Cells - Carotid, donor1	11285-116I7	22.98	5.81	4.04	0.00	0.25	0.00	0.25
Smooth Muscle Cells - Carotid, donor2	11362-117I3	67.33	0.00	18.36	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	8.58	5.25	2.86	0.00	0.48	0.00	0.48
Smooth Muscle Cells - Colonic, donor1	11239-116D6	10.91	1.92	2.06	0.15	0.00	0.15	0.29
Smooth Muscle Cells - Colonic, donor2	11320-117D6	10.98	3.44	1.08	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Colonic, donor3	11396-118D1	11.02	2.94	1.89	0.31	0.21	0.00	0.21
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	16.55	9.90	8.20	1.08	0.62	1.08	0.31
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	9.70	3.23	3.23	2.16	2.16	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	8.07	8.37	5.68	0.30	0.90	0.90	0.90
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	8.88	4.44	1.71	0.68	1.02	0.34	0.34
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	26.15	0.86	0.55	0.00	0.08	0.00	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	20.73	4.53	2.01	0.50	0.40	0.50	0.10
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	26.85	10.47	4.78	0.91	1.59	0.68	0.23
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	9.06	11.47	10.26	0.60	0.60	1.81	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	11.66	9.54	5.56	0.26	1.06	0.79	0.53
Smooth Muscle Cells - Prostate, donor1	11257-116F6	16.11	10.25	3.46	1.07	0.53	0.00	0.40
Smooth Muscle Cells - Prostate, donor2	11335-117F3	17.91	4.88	2.38	0.63	0.38	0.25	0.25
Smooth Muscle Cells - Prostate, donor3	11465-119B7	8.88	2.03	1.78	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	19.15	8.29	8.90	0.90	0.75	0.60	0.00
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	14.25	6.00	4.50	0.00	0.75	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	63.32	20.68	27.14	0.00	10.34	1.29	3.88
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	20.46	8.84	4.19	0.47	1.40	0.47	0.47
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	9.59	3.53	2.02	0.50	0.00	2.02	0.00
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	13.79	7.21	3.45	0.00	1.25	0.63	0.00
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	7.37	2.06	3.24	0.29	0.29	0.00	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	13.66	3.42	3.50	0.17	0.75	0.08	0.33
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	12.15	1.87	2.80	0.47	0.00	0.00	0.47
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	14.39	6.04	4.89	0.14	0.86	0.43	0.00
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	12.75	13.51	6.12	0.00	0.76	1.78	0.25
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	7.15	5.83	6.02	0.38	0.75	0.38	0.38
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	9.08	3.49	2.79	0.98	0.14	0.70	0.00
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	10.98	3.10	2.18	0.67	0.08	0.08	0.08
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	4.29	1.90	3.33	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	17.37	4.65	4.89	0.00	0.49	1.22	0.24
Smooth Muscle Cells - Uterine, donor1	11258-116F7	8.40	7.95	2.87	1.10	0.44	0.00	0.88
Smooth Muscle Cells - Uterine, donor3	11466-119B8	8.19	2.05	2.34	0.29	0.00	0.00	0.29
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	12.24	2.33	2.14	0.19	0.00	0.00	0.78
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	12.96	3.70	2.12	0.26	1.06	0.26	0.53
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	9.67	2.60	0.74	0.00	0.00	0.00	0.37
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	15.81	6.47	1.08	0.36	0.00	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	10.50	7.10	1.70	0.85	0.85	0.28	0.85
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	10.63	10.63	5.91	0.79	0.79	0.00	0.00
Smooth muscle cells - airway, control, donor1	11966-126D4	14.73	1.78	3.05	0.00	0.25	0.25	0.00
Smooth muscle cells - airway, control, donor2	11967-126D5	15.17	1.60	2.40	0.00	0.00	0.00	0.00
Smooth muscle cells - airway, control, donor3	11968-126D6	13.79	6.69	2.09	0.42	1.25	0.00	0.00
Smooth muscle cells - airway, control, donor4	11969-126D7	11.00	2.29	2.29	0.00	0.00	0.00	0.00
Synoviocyte, donor1	11291-117A4	18.01	6.90	1.68	1.51	0.50	0.00	0.17
Synoviocyte, donor2	11368-117I9	8.72	3.86	2.85	0.67	1.01	0.17	0.17
Synoviocyte, donor3	11440-118H9	8.94	5.36	1.56	0.45	0.00	0.00	0.45
Trabecular Meshwork Cells, donor1	11532-120A2	17.15	9.65	7.86	0.71	1.43	0.71	0.36
Trabecular Meshwork Cells, donor2	11612-122A1	5.95	0.00	3.96	0.00	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	12.74	3.01	2.55	0.46	0.69	0.00	0.00
Tracheal Epithelial Cells, donor1	11292-117A5	11.40	3.15	3.37	0.29	0.22	0.29	0.29
Tracheal Epithelial Cells, donor2	11369-118A1	9.28	3.87	3.09	0.77	0.39	0.00	0.39
Tracheal Epithelial Cells, donor3	11441-118I1	2.29	1.72	3.44	0.00	0.57	0.00	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	30.14	13.16	5.66	2.34	0.37	0.37	0.74
Urethra, donor2	10319-105A4	7.19	12.59	17.98	0.00	1.80	0.00	0.00
Urothelial Cells, donor1	11520-119H8	15.14	4.78	2.92	1.06	0.53	0.00	0.27
Urothelial Cells, donor2	11600-120H7	10.41	3.61	3.20	0.00	0.00	0.00	0.00
Urothelial Cells, donor3	11681-122H7	11.92	4.58	2.75	0.46	0.46	0.00	0.92
Urothelial cells, donor0	11216-116B1	17.39	2.67	2.90	0.89	0.45	0.00	0.22
Whole blood (ribopure), donor090309, donation1	12179-129A1	71.18	13.35	24.02	0.00	0.00	3.56	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	80.06	7.15	28.59	0.00	0.00	0.00	1.43
Whole blood (ribopure), donor090309, donation3	12181-129A3	93.78	6.85	15.06	0.68	2.74	1.37	1.37
Whole blood (ribopure), donor090325, donation1	12176-128I7	86.77	11.71	19.97	0.34	0.69	1.38	0.34
Whole blood (ribopure), donor090325, donation2	12177-128I8	64.49	10.46	22.08	0.58	0.00	0.58	0.58
Whole blood (ribopure), donor090612, donation1	12182-129A4	57.27	6.25	21.87	0.00	2.08	3.12	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	43.14	11.01	22.03	0.00	0.92	1.84	0.92
Whole blood (ribopure), donor090612, donation3	12184-129A6	74.86	8.22	20.08	0.91	1.83	0.00	0.91
Wilms' tumor cell line:G-401	10809-111A8	16.65	3.58	3.58	0.37	0.37	0.00	0.37
Wilms' tumor cell line:HFWT	10597-108E3	17.60	7.04	2.64	0.00	0.00	0.00	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	24.02	48.88	15.64	6.14	4.75	3.91	1.12
achilles tendon, donor2	10292-104G4	12.40	10.33	6.20	0.00	2.07	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	16.57	16.57	13.51	1.02	2.04	1.53	1.02
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	50.38	9.52	20.90	0.70	0.46	0.46	2.09
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	37.04	9.85	14.24	0.71	1.07	0.24	0.59
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	23.40	22.04	26.94	1.90	2.18	1.09	1.36
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	13.21	16.87	11.24	1.41	1.12	1.97	0.28
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	30.24	11.84	11.21	1.06	0.42	1.06	1.27
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	22.59	11.71	13.88	1.09	0.54	1.91	0.27
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	28.64	12.34	4.41	0.88	0.88	0.88	0.44
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	20.42	6.94	15.93	0.41	1.23	2.04	0.00
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	34.17	15.92	23.69	1.16	0.39	1.55	0.39
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	17.30	10.12	11.59	1.29	0.92	0.55	1.84
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	19.50	19.50	11.70	0.00	7.80	0.00	3.90
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	21.15	15.34	13.71	1.86	2.56	0.70	0.23
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	38.84	6.21	10.10	0.78	0.78	0.00	0.52
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	46.47	4.68	6.14	0.00	0.88	0.29	0.88
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	50.19	1.86	2.32	0.00	0.46	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	21.39	11.93	10.69	0.82	0.41	0.82	0.41
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	8.29	1.53	0.00	0.00	0.61	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	37.98	2.13	4.27	0.00	0.00	0.43	1.28
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	36.40	3.03	3.03	0.00	0.00	0.30	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	40.20	3.37	5.05	1.44	0.24	0.72	0.00
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	19.60	7.35	6.46	0.22	0.22	0.89	0.00
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	12.67	10.34	9.34	0.67	1.67	0.00	1.33
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	5.57	26.01	16.72	0.00	3.72	1.86	3.72
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	10.92	12.05	7.91	3.01	2.26	0.75	0.38
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	15.26	15.26	23.55	0.87	1.31	1.31	2.18
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	5.62	29.99	28.12	1.87	1.87	1.87	0.00
adenocarcinoma cell line:IM95m	10796-110I4	21.43	6.36	10.36	0.24	0.71	0.24	0.94
adipose tissue, adult, pool1	10010-101C1	21.25	4.50	7.14	0.31	0.31	0.16	0.16
adipose, donor1	10184-103D4	26.39	7.04	11.73	2.35	0.00	0.59	1.17
adipose, donor2	10185-103D5	29.60	2.84	10.95	0.41	0.41	0.00	0.00
adipose, donor3	10186-103D6	34.85	7.35	12.80	0.54	1.36	0.82	2.72
adipose, donor4	10187-103D7	63.27	10.40	24.27	2.60	6.93	0.00	6.93
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	25.09	6.15	8.52	1.26	0.32	0.32	0.47
adrenal gland, adult, pool1	10081-102A9	18.19	0.00	3.64	0.00	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	15.88	28.15	12.94	4.80	1.47	0.80	0.40
alveolar cell carcinoma cell line:SW 1573	10708-109H6	15.01	8.22	10.00	0.36	0.71	0.00	1.43
amniotic membrane cells, donor1	12235-129G3	59.35	35.47	7.19	5.56	1.39	0.23	0.70
amniotic membrane cells, donor2	12236-129G4	42.26	11.83	3.72	2.03	0.00	0.00	0.68
amniotic membrane cells, donor3	12237-129G5	42.42	22.68	6.78	3.24	1.47	0.29	1.18
amygdala - adult, donor10196	10167-103B5	23.72	4.74	8.30	2.37	2.37	1.19	3.56
amygdala, adult, donor10252	10151-102I7	45.01	5.88	6.08	1.62	1.42	0.00	1.01
amygdala, newborn, donor10223	10360-105E9	21.95	26.47	15.82	3.55	1.61	2.26	2.58
anaplastic carcinoma cell line:8305C	10428-106D5	22.41	7.26	12.10	0.25	0.76	0.89	0.89
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	17.43	8.16	4.63	0.66	1.10	0.88	0.22
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	42.42	17.04	17.04	2.67	3.67	0.33	1.34
aorta, adult, pool1	10052-101G7	28.05	6.08	12.36	0.98	1.18	0.20	1.18
appendix, adult	10189-103D9	28.33	19.79	17.08	0.39	1.55	1.16	0.78
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	23.04	3.44	5.50	0.34	1.03	0.00	1.38
artery, adult	10190-103E1	20.38	2.72	4.08	0.00	0.00	0.00	2.72
astrocytoma cell line:TM-31	10425-106D2	31.00	6.52	7.10	1.16	0.14	1.16	0.72
b cell line:RPMI1788	10427-106D4	42.38	12.34	11.60	2.68	1.34	0.74	0.59
basal cell carcinoma cell line:TE 354.T	10702-109G9	13.87	5.83	3.33	0.83	0.28	0.00	0.00
bile duct carcinoma cell line:HuCCT1	10432-106D9	21.73	12.60	9.92	0.89	0.79	0.89	0.89
bile duct carcinoma cell line:TFK-1	10496-107C1	17.57	8.87	5.36	0.50	0.84	0.17	0.33
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	25.17	6.71	2.24	0.00	0.00	0.00	0.56
bladder, adult, pool1	10011-101C2	28.90	8.58	10.54	1.30	1.74	0.22	1.30
blood, adult, pool1	10053-101G8	31.00	2.21	19.93	0.00	0.00	2.21	2.21
bone marrow stromal cell line:StromaNKtert	10686-109F2	9.42	8.56	3.43	0.00	0.86	0.00	2.57
bone marrow, adult	10192-103E3	20.24	4.72	8.10	2.70	1.35	0.67	0.67
brain, adult, donor1	10084-102B3	15.38	10.25	6.15	2.05	0.00	0.00	3.08
brain, adult, pool1	10012-101C3	20.49	3.34	6.12	2.90	0.78	0.22	0.78
brain, fetal, pool1	10085-102B4	24.04	0.00	13.36	0.00	0.00	0.00	5.34
breast carcinoma cell line:MCF7	10482-107A5	18.83	67.72	27.42	7.93	6.94	0.66	3.30
breast carcinoma cell line:MDA-MB-453	10419-106C5	65.53	31.70	12.48	3.37	2.62	0.25	1.75
breast, adult, donor1	10080-102A8	15.15	0.00	6.94	0.63	0.63	0.00	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	14.23	3.05	15.88	1.14	1.14	0.64	1.27
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	17.93	21.95	18.24	2.16	1.55	0.31	1.24
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	20.03	20.03	4.60	1.84	1.15	0.00	0.69
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	14.77	16.70	6.54	0.73	1.94	0.24	0.24
carcinoid cell line:NCI-H1770	10703-109H1	16.93	6.11	8.46	1.88	2.35	0.00	0.94
carcinoid cell line:NCI-H727	10735-110B6	35.22	9.84	12.58	1.42	1.09	0.88	0.77
carcinoid cell line:SK-PN-DW	10719-109I8	10.46	4.44	3.49	0.32	0.63	0.00	0.63
carcinosarcoma cell line:JHUCS-1	10642-109A3	27.68	2.93	5.86	0.00	1.06	0.27	1.33
caudate nucleus - adult, donor10196	10177-103C6	27.63	6.91	16.12	2.30	1.15	0.00	2.30
caudate nucleus, adult, donor10252	10164-103B2	44.84	10.37	11.21	1.51	2.34	0.00	2.18
caudate nucleus, adult, donor10258	10379-105H1	14.52	16.05	14.52	2.29	3.82	0.00	4.58
caudate nucleus, newborn, donor10223	10354-105E3	16.85	28.57	21.97	2.93	3.66	1.10	3.66
cerebellum - adult, donor10196	10173-103C2	90.31	0.00	20.39	0.00	0.00	0.00	2.91
cerebellum, adult, donor10252	10166-103B4	131.95	2.78	9.61	0.43	1.07	0.21	2.14
cerebellum, adult, pool1	10083-102B2	35.87	0.34	2.41	0.34	0.00	0.00	0.34
cerebellum, newborn, donor10223	10357-105E6	67.25	3.32	7.47	0.00	0.83	0.00	0.83
cerebral meninges, adult	10188-103D8	17.65	10.09	7.06	2.52	0.50	0.00	0.25
cerebrospinal fluid, donor2	10294-104G6	4.39	2.92	4.39	0.73	1.46	0.00	1.46
cervical cancer cell line:D98-AH2	10552-107I3	15.53	6.47	11.79	0.86	1.29	0.14	1.44
cervical cancer cell line:ME-180	10553-107I4	43.75	26.02	5.80	3.15	1.99	0.17	0.50
cervix, adult, pool1	10013-101C4	39.69	6.51	10.81	0.31	0.94	0.42	1.68
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	14.07	10.73	7.11	1.25	1.81	1.11	0.56
chondrosarcoma cell line:SW 1353	10700-109G7	5.23	10.45	3.92	1.31	1.31	0.00	1.31
choriocarcinoma cell line:BeWo	10423-106C9	15.53	12.05	8.20	2.24	1.24	1.12	0.50
choriocarcinoma cell line:SCH	10785-110H2	19.10	21.07	2.96	2.46	0.49	0.00	0.12
choriocarcinoma cell line:T3M-3	10618-108G6	8.06	26.80	13.28	1.66	0.24	0.71	1.42
chorionic membrane cells, donor1	12238-129G6	32.20	15.10	2.56	1.99	0.85	0.28	0.28
chorionic membrane cells, donor2	12239-129G7	25.06	4.97	2.68	0.60	0.30	0.10	0.30
chorionic membrane cells, donor3	12240-129G8	23.08	7.69	4.95	1.10	0.55	0.55	0.55
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	7.07	10.10	14.14	2.02	1.01	1.01	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	14.60	11.14	14.22	1.15	0.77	2.50	0.58
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	17.32	10.77	19.01	0.42	1.06	1.27	1.27
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	13.35	7.19	8.47	0.77	0.77	0.51	0.51
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	16.21	7.01	11.37	0.48	0.97	0.48	0.48
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	17.31	8.76	8.96	0.61	0.61	0.61	0.81
chronic myelogenous leukemia cell line:K562	10454-106G4	19.43	16.78	18.26	1.77	2.36	0.88	1.77
chronic myelogenous leukemia cell line:KU812	10409-106B4	35.45	18.50	21.37	2.87	1.04	2.87	1.30
clear cell carcinoma cell line:JHOC-5	10638-108I8	15.09	7.09	12.34	1.83	1.60	0.91	0.69
clear cell carcinoma cell line:TEN	10636-108I6	21.51	29.15	12.49	2.60	2.60	1.21	0.52
colon carcinoma cell line:CACO-2	10513-107D9	34.41	20.50	11.71	2.75	2.38	1.28	1.46
colon carcinoma cell line:COLO-320	10420-106C6	32.69	5.32	3.80	1.14	1.52	0.38	0.76
colon, adult, donor1	10082-102B1	28.56	11.90	4.76	0.00	0.00	0.00	1.19
colon, adult, pool1	10014-101C5	31.61	3.76	4.11	0.35	0.71	0.24	1.06
colon, fetal, donor1	10070-101I7	14.83	3.71	1.24	0.00	0.00	0.00	0.00
common myeloid progenitor CMP, donor1	12130-128D6	114.59	45.84	110.00	9.17	4.58	18.33	4.58
common myeloid progenitor CMP, donor2	12134-128E1	25.04	25.04	25.04	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	20.40	42.07	11.05	2.12	3.82	0.85	1.27
cord blood derived cell line:COBL-a 24h infection	10453-106G3	15.24	29.58	13.73	1.66	1.36	0.60	1.36
cord blood derived cell line:COBL-a untreated	10449-106F8	16.22	32.29	15.37	1.69	2.40	1.27	1.13
corpus callosum, adult, pool1	10042-101F6	52.85	2.21	5.20	0.33	0.11	0.55	0.77
cruciate ligament, donor2	10295-104G7	17.83	4.86	9.73	0.81	0.81	0.81	0.81
diaphragm, fetal, donor1	10069-101I6	14.45	8.03	4.01	0.80	0.80	0.00	1.61
diencephalon, adult	10193-103E4	14.64	1.68	3.36	0.72	0.24	0.24	0.72
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	13.55	13.32	18.37	1.61	1.84	1.61	0.69
ductal cell carcinoma cell line:KLM-1	10438-106E6	32.05	39.75	16.67	4.62	3.59	2.05	1.28
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	13.72	8.18	3.85	0.72	0.72	0.72	0.00
ductus deferens, adult	10196-103E7	39.87	9.97	3.49	0.00	0.50	0.00	1.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	21.60	4.32	5.76	0.00	0.00	0.00	1.44
duodenum, fetal, donor1, tech_rep2	10071-101I8	35.31	5.15	7.36	1.47	2.94	0.00	2.21
dura mater, adult, donor1	10041-101F5	45.01	9.58	12.97	1.65	1.24	0.41	1.40
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	19.10	14.66	5.11	2.22	0.67	1.11	0.22
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	16.77	8.45	5.59	0.43	1.43	0.14	0.14
embryonic pancreas cell line:1B2C6	10604-108F1	3.70	17.88	13.57	1.85	3.08	0.00	1.23
embryonic pancreas cell line:1C3D3	10605-108F2	5.75	10.29	5.75	0.91	1.51	0.30	0.91
embryonic pancreas cell line:1C3IKEI	10606-108F3	9.88	22.85	10.50	1.85	4.01	0.93	1.23
embryonic pancreas cell line:2C6	10603-108E9	2.63	14.45	23.64	2.63	3.94	1.31	10.51
endometrial carcinoma cell line:OMC-2	10497-107C2	16.09	14.75	10.39	1.34	1.34	1.01	0.34
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	18.49	9.61	10.33	1.09	2.17	0.72	0.54
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	17.85	17.05	7.88	0.64	1.13	0.16	0.16
epidermoid carcinoma cell line:A431	10426-106D3	29.90	24.68	5.00	1.89	1.67	1.00	0.33
epidermoid carcinoma cell line:Ca Ski	10431-106D8	39.48	24.09	7.81	2.09	1.10	0.77	0.22
epididymis, adult	10197-103E8	24.49	9.42	10.88	0.42	1.26	0.21	2.09
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	17.21	7.10	6.03	1.24	0.35	0.18	0.53
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	12.98	9.83	5.11	0.00	0.39	0.79	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	29.88	21.10	11.27	1.31	3.01	0.52	0.79
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	31.20	12.30	7.38	0.59	1.18	0.49	0.59
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	31.14	14.12	11.65	1.46	2.69	0.45	0.90
esophagus, adult, pool1	10015-101C6	34.40	6.58	6.37	0.64	0.85	0.21	0.74
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	36.82	25.30	5.51	4.26	1.50	0.13	0.63
eye - muscle inferior rectus, donor1	10272-104E2	19.32	4.83	14.49	0.00	0.00	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	10.52	4.21	4.21	0.00	2.10	2.10	4.21
eye - muscle medial, donor2	10299-104H2	5.95	7.44	7.44	0.00	1.49	0.00	1.49
eye - muscle superior, donor2	10297-104G9	14.90	12.61	12.61	0.00	1.15	0.00	1.15
eye - vitreous humor, donor1	10268-104D7	29.15	11.66	5.83	0.00	0.00	0.00	0.00
eye, fetal, donor1	10054-101G9	28.73	2.29	2.29	0.25	1.27	0.00	0.25
fibrosarcoma cell line:HT-1080	10758-110E2	8.08	6.28	6.28	0.77	0.90	0.13	0.13
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	17.09	22.79	15.67	1.19	2.14	0.47	2.14
frontal lobe, adult, pool1	10040-101F4	32.74	7.22	11.07	3.00	0.56	0.00	1.97
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	36.93	54.35	15.91	9.01	7.21	1.20	2.70
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	24.14	13.99	15.36	1.55	2.38	1.83	1.28
gall bladder, adult	10198-103E9	25.11	6.04	7.00	0.72	0.48	0.24	0.72
gamma delta positive T cells, donor1	11937-126A2	41.87	8.59	35.97	1.61	1.07	6.98	1.07
gamma delta positive T cells, donor2	11938-126A3	47.43	11.20	38.10	1.87	2.99	7.47	0.75
gastric adenocarcinoma cell line:MKN1	10614-108G2	20.28	19.64	5.70	2.96	1.69	0.63	1.27
gastric adenocarcinoma cell line:MKN45	10612-108F9	30.95	6.19	8.51	1.16	0.77	0.00	0.58
gastric cancer cell line:AZ521	10549-107H9	21.81	6.89	2.13	0.98	0.98	0.49	0.98
gastric cancer cell line:GSS	10560-108A2	34.78	19.22	18.30	1.83	2.75	0.00	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	37.47	20.10	8.68	1.14	0.91	0.69	0.91
giant cell carcinoma cell line:LU65	10487-107B1	8.61	14.00	12.16	0.92	1.61	0.92	1.15
giant cell carcinoma cell line:Lu99B	10433-106E1	22.53	8.26	6.16	1.68	1.12	0.56	0.70
glassy cell carcinoma cell line:HOKUG	10688-109F4	26.44	23.45	6.24	2.00	2.24	0.00	0.75
glioblastoma cell line:A172, tech_rep1	10444-106F3	14.99	8.55	5.49	0.42	0.32	0.00	0.74
glioblastoma cell line:A172, tech_rep2	10444-106F3	15.73	10.11	6.46	0.42	0.98	0.14	0.70
glioblastoma cell line:T98G	10485-107A8	22.52	11.59	4.75	0.55	0.77	0.33	0.99
glioma cell line:GI-1	10413-106B8	36.90	14.64	4.39	0.88	0.59	0.59	0.29
globus pallidus - adult, donor10196	10175-103C4	21.87	5.10	12.39	1.46	0.00	0.73	2.19
globus pallidus, adult, donor10252	10161-103A8	62.24	3.91	5.13	0.98	1.22	0.00	0.49
globus pallidus, adult, donor10258	10367-105F7	15.06	1.37	5.48	0.00	1.37	0.00	1.37
globus pallidus, newborn, donor10223	10364-105F4	16.52	12.79	5.86	2.13	1.60	0.53	1.60
granulocyte macrophage progenitor, donor1	12131-128D7	144.38	36.71	73.41	7.34	9.79	4.89	4.89
granulocyte macrophage progenitor, donor2	12135-128E2	32.79	0.00	32.79	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	20.91	5.23	10.45	0.00	10.45	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	18.88	7.04	5.44	0.32	1.28	0.32	0.32
hIPS +CCl2, biol_rep1	14383-156B9	12.40	11.94	16.53	1.38	0.46	0.46	0.46
hIPS +CCl2, biol_rep2	14384-156C1	9.60	8.23	10.06	1.37	1.83	1.37	0.91
hIPS +CCl2, biol_rep3	14385-156C2	15.46	12.88	10.31	1.29	0.64	0.64	0.64
hIPS, biol_rep1	14380-156B6	7.19	12.94	15.81	2.87	2.87	0.00	1.44
hIPS, biol_rep2	14381-156B7	14.40	10.97	13.03	1.37	2.06	1.37	0.00
hIPS, biol_rep3	14382-156B8	19.86	3.31	11.03	0.00	2.21	2.21	2.21
hairy cell leukemia cell line:Mo	10712-109I1	19.25	20.69	11.49	3.16	0.57	0.86	0.29
heart - mitral valve, adult	10205-103F7	19.73	6.88	8.97	1.20	0.90	0.60	1.79
heart - pulmonic valve, adult	10206-103F8	21.44	7.06	9.41	2.09	0.26	0.26	1.57
heart - tricuspid valve, adult	10207-103F9	23.31	10.82	9.99	1.67	0.83	1.67	1.67
heart, adult, diseased post-infarction, donor1	10050-101G5	19.39	17.75	7.14	3.88	1.02	0.20	1.02
heart, adult, diseased, donor1	10051-101G6	18.31	8.09	8.09	0.43	0.85	0.00	0.85
heart, adult, pool1	10016-101C7	19.55	3.22	5.98	0.23	0.69	0.23	0.92
heart, fetal, pool1	10046-101G1	52.37	3.18	5.96	0.62	0.62	0.21	0.51
hepatic mesenchymal tumor cell line:LI90	10778-110G4	21.60	5.55	3.39	0.93	0.00	0.31	0.00
hepatoblastoma cell line:HuH-6	10633-108I3	5.95	15.46	8.32	1.19	1.19	0.00	1.19
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	21.22	16.57	5.75	1.88	0.88	0.44	0.66
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	20.88	17.11	6.19	1.21	1.21	0.24	1.09
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	22.23	15.66	6.87	1.21	1.72	0.20	0.81
hepatoma cell line:Li-7	10484-107A7	21.58	3.56	3.34	0.56	0.44	0.44	0.11
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	12.76	12.26	8.94	1.41	1.01	1.11	0.30
hippocampus - adult, donor10196	10169-103B7	21.77	5.68	16.09	1.89	0.00	0.00	0.95
hippocampus, adult, donor10252	10153-102I9	48.37	6.53	6.33	1.63	1.43	0.00	0.61
hippocampus, adult, donor10258	10374-105G5	18.92	8.96	22.41	2.99	0.50	0.00	2.49
hippocampus, newborn, donor10223	10363-105F3	15.51	16.92	14.10	1.06	0.35	0.70	3.17
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	23.80	30.52	12.82	4.27	3.66	2.44	1.22
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	10.41	17.67	12.96	2.36	1.57	1.57	0.79
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	11.43	27.67	10.92	1.78	1.02	0.25	1.02
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	25.94	7.89	9.02	3.38	1.69	1.13	0.56
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	20.40	9.55	8.52	1.03	0.77	0.77	1.03
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	20.50	7.59	10.63	1.52	0.00	0.76	0.76
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	31.82	16.64	22.19	1.46	0.00	0.58	1.17
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	36.41	9.48	21.54	0.86	0.43	0.65	0.65
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	26.69	18.77	24.19	2.50	0.83	1.67	2.09
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	18.00	10.42	9.95	0.24	0.24	0.47	0.71
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	16.88	7.39	13.50	0.80	0.48	0.64	0.48
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	18.85	10.10	7.41	0.67	0.00	0.00	0.67
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	13.30	16.90	10.17	2.03	1.88	0.47	1.10
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	12.77	13.76	15.72	3.44	1.47	2.95	0.98
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	14.84	27.06	20.95	2.62	1.75	4.36	0.87
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	22.15	6.49	11.26	1.34	0.19	0.19	0.57
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	16.13	9.16	8.29	1.31	0.87	0.00	0.44
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	29.99	9.50	14.99	1.00	1.00	1.00	1.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	31.46	2.26	10.93	0.38	0.19	0.38	0.57
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	24.55	2.27	11.82	0.45	0.00	0.00	1.82
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	29.13	3.45	10.65	0.31	0.00	0.31	0.63
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	13.06	3.92	7.19	0.49	0.82	0.33	0.82
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	12.48	3.48	6.10	0.00	0.29	1.16	0.29
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	19.13	5.68	7.77	1.20	0.60	1.20	0.30
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	11.82	16.81	8.31	2.59	0.92	1.48	0.92
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	13.12	14.83	11.13	1.14	1.43	1.43	1.43
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	16.74	27.36	13.47	4.49	2.04	2.86	1.63
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	19.01	5.99	7.75	1.06	0.70	0.70	0.70
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	16.79	10.45	8.24	0.63	1.27	0.95	0.32
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	19.07	10.59	6.66	2.12	0.61	1.21	0.91
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	18.10	2.59	12.93	0.00	0.00	0.00	0.52
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	21.25	3.32	15.28	0.66	3.32	0.00	1.33
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	21.81	12.06	13.60	0.51	0.26	0.77	1.80
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	16.62	6.39	8.44	0.26	0.77	0.77	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	16.66	9.09	11.36	1.51	4.54	0.00	2.27
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	12.10	8.40	11.43	0.00	0.34	0.67	0.67
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	12.32	18.11	10.38	3.14	2.42	2.66	0.24
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	19.61	21.39	8.91	3.57	1.34	1.78	1.78
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	12.20	24.39	15.12	4.39	1.46	0.00	1.95
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	19.25	10.39	8.86	2.44	0.92	0.92	0.61
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	68.32	16.27	22.77	0.00	0.00	0.00	3.25
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	28.13	13.24	14.23	2.98	1.65	0.66	0.99
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	26.82	8.21	16.42	0.00	0.55	0.55	2.19
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	32.21	8.32	14.11	1.45	1.09	1.45	1.09
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	28.83	10.32	13.52	0.71	0.00	0.71	0.71
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	8.35	3.58	11.93	0.00	0.00	1.19	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	20.45	6.77	10.43	0.68	0.41	0.81	0.27
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	13.20	7.54	8.62	0.00	1.08	0.00	0.54
immature langerhans cells, donor1	11904-125F5	37.77	12.83	16.71	2.18	2.42	2.66	0.48
immature langerhans cells, donor2	11905-125F6	64.16	27.72	22.97	3.17	1.58	1.58	0.00
insula, adult, pool1	10039-101F3	39.08	10.69	12.40	4.92	0.95	0.09	2.56
keratoacanthoma cell line:HKA-1	10791-110H8	11.06	5.85	2.28	0.65	0.33	0.33	0.33
kidney, adult, pool1	10017-101C8	25.33	7.21	5.11	0.80	0.80	0.10	0.40
kidney, fetal, pool1	10045-101F9	48.31	8.49	7.00	1.56	0.64	0.07	1.06
large cell lung carcinoma cell line:IA-LM	10509-107D5	23.58	26.13	19.31	3.12	2.41	2.13	2.13
large cell lung carcinoma cell line:NCI-H460	10839-111E2	8.02	2.76	4.98	0.28	0.14	0.69	0.41
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	17.07	20.18	7.16	2.02	1.28	0.18	0.73
left atrium, adult, donor1	10079-102A7	7.63	7.63	4.90	0.00	0.00	0.00	0.54
left ventricle, adult, donor1	10078-102A6	11.12	5.56	5.56	0.00	0.51	0.00	1.01
leiomyoblastoma cell line:G-402	10721-110A1	12.04	18.33	8.48	1.37	1.92	0.00	0.27
leiomyoma cell line:10964C	10569-108B2	8.26	6.47	3.95	0.00	0.72	0.00	0.00
leiomyoma cell line:15242A	10570-108B3	6.52	4.89	2.17	1.09	0.54	0.00	0.00
leiomyoma cell line:15425	10571-108B4	10.44	6.80	3.64	0.24	0.73	0.24	0.00
leiomyosarcoma cell line:Hs 5.T	10722-110A2	38.10	0.00	0.00	0.00	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	11.50	8.36	7.32	0.00	1.05	0.00	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	23.49	10.39	10.74	0.59	1.30	1.53	0.24
liposarcoma cell line:KMLS-1	10782-110G8	14.37	3.91	2.34	0.00	0.16	0.31	0.16
liposarcoma cell line:SW 872	10726-110A6	22.30	14.26	9.14	1.46	2.19	1.22	0.85
liver, adult, pool1	10018-101C9	17.02	7.62	3.08	0.49	0.00	0.32	0.49
liver, fetal, pool1	10086-102B5	6.58	2.82	5.64	0.00	0.00	0.00	0.00
locus coeruleus - adult, donor10196	10182-103D2	18.08	6.71	6.56	1.46	0.58	0.44	0.44
locus coeruleus, adult, donor10252	10165-103B3	38.02	4.43	6.27	2.21	0.55	0.00	1.11
locus coeruleus, adult, donor10258	10375-105G6	12.98	4.23	3.67	0.56	0.28	0.28	0.28
locus coeruleus, newborn, donor10223	10362-105F2	32.39	14.30	8.83	1.26	1.26	1.26	0.84
lung adenocarcinoma cell line:A549	10499-107C4	12.73	7.06	3.60	0.55	0.42	0.00	0.83
lung adenocarcinoma cell line:PC-14	10408-106B3	22.75	37.23	17.24	6.89	4.83	0.00	2.76
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	35.85	12.92	19.11	2.24	1.71	2.11	2.11
lung, adult, pool1	10019-101D1	33.78	5.20	5.08	1.06	0.24	0.24	0.95
lung, fetal, donor1	10068-101I5	43.67	8.28	12.56	2.85	0.57	0.86	1.14
lung, right lower lobe, adult, donor1	10075-102A3	22.45	2.75	9.16	0.46	0.46	0.00	0.46
lymph node, adult, donor1	10077-102A5	18.93	12.78	20.83	0.47	1.42	1.42	1.89
lymphangiectasia cell line:DS-1	10727-110A7	19.51	28.27	12.71	1.32	2.19	1.53	0.66
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	27.17	6.49	12.68	0.60	0.91	1.51	0.30
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	38.23	39.08	18.69	5.10	4.25	0.85	1.70
mature adipocyte, donor1	12231-129F8	17.76	5.33	3.11	0.89	0.00	0.44	0.00
mature adipocyte, donor2	12232-129F9	20.55	7.47	5.40	0.42	0.21	0.42	0.62
mature adipocyte, donor3	12233-129G1	16.59	7.11	2.61	0.47	0.47	0.24	0.95
mature adipocyte, donor4	12234-129G2	16.06	3.95	2.90	1.05	0.79	0.26	0.79
maxillary sinus tumor cell line:HSQ-89	10414-106B9	28.11	5.96	16.68	0.95	2.62	0.48	2.38
medial frontal gyrus - adult, donor10196	10170-103B8	20.30	1.13	12.41	4.51	1.13	1.13	2.26
medial frontal gyrus, adult, donor10252	10150-102I6	48.92	8.83	11.95	1.84	1.29	0.18	1.66
medial frontal gyrus, adult, donor10258	10368-105F8	14.93	13.66	10.80	2.86	1.27	0.32	1.91
medial frontal gyrus, newborn, donor10223	10352-105E1	22.60	25.16	20.90	1.28	0.43	1.28	2.56
medial temporal gyrus - adult, donor10196	10183-103D3	21.77	8.94	17.04	3.54	1.18	0.34	2.70
medial temporal gyrus, adult, donor10252	10156-103A3	47.96	8.06	9.55	2.76	1.27	0.42	1.49
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	7.71	9.63	21.19	7.71	0.00	1.93	3.85
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	28.71	0.00	14.35	14.35	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	19.74	26.92	20.10	1.79	1.79	0.72	1.79
medulla oblongata - adult, donor10196	10174-103C3	20.77	3.89	12.98	0.65	0.65	0.65	0.65
medulla oblongata, adult, donor10252	10155-103A2	49.85	5.57	4.80	2.17	0.93	0.00	0.93
medulla oblongata, adult, pool1	10038-101F2	35.43	4.98	6.53	0.98	0.65	0.41	0.49
medulla oblongata, newborn, donor10223	10361-105F1	27.08	10.42	8.33	1.74	0.69	0.00	0.35
medulloblastoma cell line:D283 Med	10838-111E1	24.58	15.50	11.29	1.99	1.33	0.89	1.11
medulloblastoma cell line:ONS-76	10759-110E3	11.74	13.45	14.06	0.98	1.35	1.35	0.86
melanoma cell line:COLO 679	10514-107E1	12.65	2.01	3.59	0.29	0.00	0.43	0.14
melanoma cell line:G-361	10465-106H6	6.79	3.26	9.77	0.81	1.09	1.63	0.81
meningioma cell line:HKBMM	10691-109F7	14.29	5.97	7.42	0.90	0.72	0.18	0.36
merkel cell carcinoma cell line:MKL-1	10843-111E6	32.60	1.76	6.17	0.00	0.00	0.00	0.88
merkel cell carcinoma cell line:MS-1	10844-111E7	31.37	9.59	16.07	2.07	1.04	0.26	0.52
mesenchymal precursor cell - adipose, donor1	11747-123G1	9.05	4.60	2.61	0.77	0.46	0.15	0.46
mesenchymal precursor cell - adipose, donor2	11748-123G2	10.18	3.45	2.00	0.18	0.36	0.00	0.00
mesenchymal precursor cell - adipose, donor3	11749-123G3	8.28	5.38	2.07	0.41	0.41	0.41	0.41
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	7.30	2.39	1.97	0.14	0.28	0.14	0.28
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	10.59	3.27	1.93	0.00	0.00	0.19	0.00
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	15.96	1.39	1.39	2.08	0.00	0.00	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	7.38	3.09	2.75	0.17	0.34	0.51	0.17
mesenchymal precursor cell - cardiac, donor2	11753-123G7	9.09	5.41	3.22	0.35	0.81	0.23	0.23
mesenchymal precursor cell - cardiac, donor3	11754-123G8	9.02	5.70	3.32	0.13	0.13	0.40	0.40
mesenchymal precursor cell - cardiac, donor4	11755-123G9	10.67	4.73	4.86	0.14	0.41	0.81	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	13.37	9.25	4.41	0.43	0.43	0.57	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	13.50	9.22	4.28	0.00	0.33	0.00	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	10.93	5.67	4.57	0.42	0.97	0.42	0.42
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	13.27	8.38	4.54	0.70	0.70	0.35	0.70
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	9.80	2.86	2.45	0.00	0.41	0.00	0.41
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	10.78	4.67	4.67	0.00	0.36	0.00	1.08
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	7.34	3.00	2.79	0.31	0.52	0.21	0.10
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	10.94	6.84	2.28	0.23	0.91	0.46	0.23
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	10.49	8.81	7.55	0.42	0.00	1.68	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	14.35	3.29	2.39	0.45	0.45	0.30	0.15
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	11.38	6.30	4.03	0.88	0.35	0.79	0.09
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	17.30	5.15	4.05	0.74	0.37	0.37	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	12.88	4.58	3.72	0.86	0.29	0.57	0.29
mesenchymal stem cell line:Hu5/E18	10568-108B1	10.10	7.16	7.16	0.00	0.84	0.84	0.42
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	10.96	3.65	1.83	0.00	0.46	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	9.21	5.12	2.56	0.00	0.26	0.00	0.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	11.26	6.02	1.05	0.79	0.00	0.00	0.52
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	13.25	6.16	1.85	0.00	0.00	0.31	0.31
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	10.12	3.53	1.65	0.71	0.24	0.24	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	14.55	3.72	1.35	0.34	0.68	0.00	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	13.75	4.32	1.18	0.00	0.00	0.00	0.39
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	11.58	1.39	0.93	0.00	0.46	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	48.30	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	11.25	2.60	1.73	0.29	0.29	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	16.29	2.68	1.34	0.67	0.45	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	12.02	3.36	1.20	0.00	0.48	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	15.40	3.67	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	8.06	2.69	1.34	0.00	0.00	0.00	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	12.28	2.46	1.23	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	10.74	4.30	2.58	0.43	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	10.94	10.94	0.00	0.00	0.00	0.00	2.73
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	0.00	5.16	5.16	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	9.42	4.22	1.30	0.97	0.32	0.00	0.65
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	4.36	1.45	5.82	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	7.46	2.13	2.13	0.53	0.00	0.00	1.07
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	4.09	3.27	1.64	0.00	0.00	0.82	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	5.44	4.28	3.50	0.39	0.00	0.39	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	10.49	4.20	4.20	4.20	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	4.97	2.98	0.00	1.99	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	9.53	4.77	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	9.49	0.59	2.96	0.59	1.19	0.00	0.59
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	8.53	1.22	4.87	1.22	1.22	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	8.23	1.90	5.07	0.63	1.27	0.00	0.63
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	8.97	3.45	0.34	0.34	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	12.90	0.00	0.00	0.00	2.15	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	3.99	3.99	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	17.22	6.89	0.00	3.44	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	13.45	1.22	1.22	0.00	0.00	0.00	0.81
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	12.71	1.59	0.79	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	14.15	1.18	0.59	0.00	0.00	0.00	0.59
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	7.48	2.49	2.81	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	22.72	4.01	2.67	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	2.37	4.73	4.73	0.00	0.00	0.00	2.37
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	7.70	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	13.77	1.38	1.38	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	6.43	4.95	1.98	0.00	0.49	0.49	0.99
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	6.73	2.24	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	12.72	4.45	1.27	0.00	0.64	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	8.87	4.43	2.01	0.40	0.00	0.40	0.81
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	13.08	2.18	4.36	0.00	0.00	0.00	2.18
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	10.14	1.27	5.07	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	13.35	6.07	1.21	1.21	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	13.56	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	10.71	4.94	1.65	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	11.71	4.17	1.19	0.60	0.60	0.00	0.20
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	7.79	4.54	2.27	0.65	0.97	0.00	0.65
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	15.28	4.07	2.04	1.02	0.00	0.00	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	12.38	15.47	5.42	0.77	0.77	0.00	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	21.03	7.56	4.96	2.13	0.71	0.24	0.71
mesothelioma cell line:ACC-MESO-4	10494-107B8	17.61	23.86	9.04	2.78	1.85	1.39	1.39
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	4.27	4.27	0.00	0.00	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	5.86	6.68	2.98	0.72	0.82	0.10	0.31
mesothelioma cell line:Mero-25	10850-111F4	10.89	6.35	4.77	0.91	0.68	0.23	0.23
mesothelioma cell line:Mero-41	10851-111F5	13.69	12.47	11.25	0.73	1.22	0.98	0.73
mesothelioma cell line:Mero-48a	10852-111F6	10.19	4.43	3.32	0.22	0.89	0.00	0.00
mesothelioma cell line:Mero-82	10853-111F7	16.82	7.10	2.89	0.26	0.00	0.00	0.26
mesothelioma cell line:Mero-83	10854-111F8	13.11	7.15	3.92	0.51	0.68	0.85	0.00
mesothelioma cell line:Mero-84	10855-111F9	14.91	14.41	7.84	1.01	0.25	0.25	1.01
mesothelioma cell line:Mero-95	10856-111G1	12.22	4.35	4.97	0.83	0.00	0.41	0.83
mesothelioma cell line:NCI-H2052	10847-111F1	14.25	9.94	4.14	0.50	0.66	0.00	0.33
mesothelioma cell line:NCI-H226	10846-111E9	9.77	15.20	4.52	0.90	1.45	0.72	0.36
mesothelioma cell line:NCI-H2452	10848-111F2	16.40	9.57	9.05	0.85	1.20	0.85	0.68
mesothelioma cell line:NCI-H28	10845-111E8	16.79	5.60	4.33	0.00	0.51	0.00	0.51
mesothelioma cell line:No36	10857-111G2	10.44	9.13	10.44	0.33	0.33	0.00	0.98
mesothelioma cell line:ONE58	10858-111G3	13.55	10.57	10.57	0.00	0.81	0.54	0.00
migratory langerhans cells, donor1	11901-125F2	32.05	15.93	8.06	3.07	0.58	0.77	1.34
migratory langerhans cells, donor2	11902-125F3	41.03	24.30	9.28	2.56	2.56	0.73	1.71
migratory langerhans cells, donor3	11903-125F4	41.28	14.90	10.23	3.59	0.72	1.08	0.90
mixed mullerian tumor cell line:HTMMT	10689-109F5	13.39	3.59	2.61	0.65	0.33	0.33	0.33
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	14.41	5.09	4.45	0.42	0.42	0.64	0.42
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	8.75	8.75	4.61	0.00	0.92	0.00	0.00
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	12.75	17.32	13.51	1.71	1.71	1.90	0.57
myelodysplastic syndrome cell line:SKM-1	10772-110F7	27.90	4.07	7.02	0.55	0.37	0.18	0.37
myeloma cell line:PCM6	10474-106I6	19.57	24.91	16.21	2.77	2.37	0.40	0.00
myxofibrosarcoma cell line:MFH-ino	10600-108E6	7.10	5.07	6.59	1.01	0.51	0.00	1.01
myxofibrosarcoma cell line:NMFH-1	10684-109E9	35.31	14.91	19.61	1.18	1.57	4.12	0.20
nasal epithelial cells, donor1, tech_rep1	12226-129F3	13.15	2.90	1.56	0.45	0.33	0.00	0.22
nasal epithelial cells, donor1, tech_rep2	12226-129F3	14.34	3.46	1.99	0.29	0.29	0.00	0.22
nasal epithelial cells, donor2	12227-129F4	34.22	4.42	5.52	1.66	2.76	0.00	0.55
neuroblastoma cell line:CHP-134	10508-107D4	29.68	3.68	28.30	0.69	1.38	0.69	2.99
neuroblastoma cell line:NB-1	10539-107G8	23.95	7.48	22.82	1.31	1.12	0.75	0.94
neuroblastoma cell line:NBsusSR	10607-108F4	39.65	12.44	4.64	1.27	1.05	0.00	1.27
neuroblastoma cell line:NH-12	10555-107I6	24.97	7.27	17.70	1.68	2.80	0.00	2.24
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	21.11	11.15	9.25	0.71	0.47	0.24	0.71
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	37.69	22.01	7.76	2.38	0.95	0.00	0.32
neuroectodermal tumor cell line:TASK1	10774-110F9	19.72	14.29	10.87	2.42	1.41	0.00	1.61
neuroepithelioma cell line:SK-N-MC	10728-110A8	8.26	29.88	17.17	3.18	5.09	0.64	3.81
neurofibroma cell line:Hs 53.T	10729-110A9	12.24	6.39	4.26	0.27	0.00	0.00	0.00
neutrophil PMN, donor1	12133-128D9	74.37	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	79.68	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	47.35	9.47	0.00	9.47	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	88.11	12.18	19.96	1.18	1.18	1.18	0.68
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	11.21	5.60	5.60	0.80	0.80	1.60	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	12.18	10.58	3.85	0.32	0.00	0.96	0.64
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	17.08	9.99	2.63	1.05	0.26	0.26	0.00
nucleus accumbens, adult, pool1	10037-101F1	31.12	8.25	11.90	3.56	1.31	0.28	1.50
occipital cortex - adult, donor10196	10172-103C1	22.66	8.24	26.78	6.18	2.06	2.06	2.06
occipital cortex, adult, donor10252	10163-103B1	57.70	7.51	8.05	2.15	0.81	0.27	1.07
occipital cortex, newborn, donor10223	10355-105E4	21.84	21.84	14.92	1.46	1.46	1.09	2.55
occipital lobe, adult, donor1	10076-102A4	18.11	6.30	14.17	1.84	0.79	0.26	2.10
occipital lobe, fetal, donor1	10073-102A1	25.32	3.00	22.74	0.00	1.72	0.43	1.29
occipital pole, adult, pool1	10036-101E9	26.65	6.70	10.17	2.68	1.18	0.16	1.18
olfactory region, adult	10195-103E6	21.21	4.59	8.60	2.29	0.38	0.00	1.53
optic nerve, donor1	10277-104E7	14.01	0.00	6.00	0.00	0.00	0.00	2.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	45.68	19.93	6.95	1.59	1.14	0.34	0.23
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	16.62	18.00	8.79	3.43	1.24	1.37	1.24
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	25.06	22.69	9.48	1.35	2.71	0.68	0.85
oral squamous cell carcinoma cell line:SAS	10544-107H4	27.26	9.82	4.74	1.27	0.81	0.69	0.46
osteoclastoma cell line:Hs 706.T	10704-109H2	14.70	3.82	1.47	0.00	0.00	0.00	0.00
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	4.67	56.99	15.88	4.67	1.87	1.87	1.87
osteosarcoma cell line:HS-Os-1	10558-107I9	19.09	8.69	4.88	0.21	0.64	0.21	0.85
ovary, adult, pool1	10020-101D2	26.03	3.49	6.20	0.61	1.14	0.17	1.75
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	8.25	4.95	5.68	0.92	0.18	0.37	0.18
pancreas, adult, donor1	10049-101G4	21.63	3.76	9.41	0.00	0.00	0.00	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	10.90	18.73	8.95	0.84	0.00	0.84	1.12
papillary adenocarcinoma cell line:8505C	10437-106E5	20.27	15.67	10.90	0.85	0.85	0.51	0.17
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	18.55	15.40	9.44	0.33	0.50	1.99	0.17
paracentral gyrus, adult, pool1	10035-101E8	31.94	8.42	9.24	2.29	1.10	0.46	1.19
parietal cortex, adult, donor10258	10373-105G4	29.36	7.34	15.41	1.47	2.20	0.73	4.40
parietal lobe - adult, donor10196	10171-103B9	15.05	4.70	16.93	1.88	0.94	0.00	0.94
parietal lobe, adult, donor10252	10157-103A4	51.59	9.69	10.55	3.14	1.14	0.29	0.29
parietal lobe, adult, pool1	10034-101E7	34.19	8.20	9.08	2.11	0.79	0.35	2.03
parietal lobe, fetal, donor1	10072-101I9	32.97	2.91	24.25	0.00	0.97	0.00	1.94
parietal lobe, newborn, donor10223	10356-105E5	26.17	29.91	22.43	1.12	1.12	0.37	1.50
parotid gland, adult	10199-103F1	21.58	7.40	5.55	0.00	0.00	0.00	0.00
penis, adult	10200-103F2	20.95	10.74	10.21	1.07	0.00	0.54	1.07
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	10.97	4.09	3.53	0.56	0.37	0.00	0.37
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	46.19	14.72	15.74	1.31	1.02	0.73	1.46
pineal gland - adult, donor10196	10179-103C8	36.77	1.94	7.10	0.00	0.65	0.00	1.94
pineal gland, adult, donor10252	10160-103A7	82.91	4.74	7.11	5.33	0.59	0.00	1.78
pineal gland, adult, donor10258	10377-105G8	25.71	1.25	9.41	1.25	0.00	0.00	1.88
pituitary gland - adult, donor10196	10180-103C9	34.40	5.06	18.21	3.04	2.02	0.00	3.04
pituitary gland, adult, donor10252	10162-103A9	76.61	7.82	13.03	1.56	2.08	0.00	4.17
pituitary gland, adult, donor10258	10378-105G9	38.31	7.66	12.77	0.85	0.00	0.00	1.70
placenta, adult, pool1	10021-101D3	37.30	12.04	6.24	2.15	0.65	0.32	0.32
plasma cell leukemia cell line:ARH-77	10840-111E3	21.32	13.38	9.14	1.59	0.79	0.66	0.66
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	100.70	18.83	22.57	2.02	1.71	2.96	2.33
pons, adult, pool1	10033-101E6	28.14	5.68	8.00	2.75	0.26	0.34	0.52
postcentral gyrus, adult, pool1	10032-101E5	29.73	8.19	9.41	3.23	0.96	0.26	2.18
promyelocytes/myelocytes PMC, donor1	12132-128D8	41.83	16.73	29.28	6.27	4.18	0.00	2.09
promyelocytes/myelocytes PMC, donor2	12136-128E3	22.03	5.51	11.02	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	11.74	0.00	23.47	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	28.84	14.27	7.72	1.75	1.31	0.73	1.02
prostate cancer cell line:PC-3	10439-106E7	31.22	35.03	15.79	1.82	2.18	1.27	1.45
prostate, adult, pool1	10022-101D4	27.21	4.90	7.98	0.63	0.73	0.18	1.09
putamen, adult, donor10196	10176-103C5	30.92	5.43	17.70	2.12	1.42	0.00	3.07
putamen, adult, donor10252	10152-102I8	27.45	3.92	7.84	3.92	1.96	0.00	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	13.11	7.65	18.58	3.28	2.19	2.19	1.09
putamen, adult, donor10258, tech_rep2	10372-105G3	16.43	7.73	11.84	2.66	1.21	0.48	2.66
putamen, newborn, donor10223	10365-105F5	15.74	14.24	11.99	1.50	1.50	1.50	2.25
rectal cancer cell line:TT1TKB	10469-106I1	35.79	67.79	11.35	8.15	3.49	0.58	2.33
rectum, fetal, donor1	10067-101I4	25.04	4.17	9.74	0.00	4.17	0.00	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	17.17	9.96	8.27	0.00	1.06	0.21	0.42
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	31.48	8.28	18.64	2.07	0.83	0.83	1.66
retina, adult, pool1	10030-101E3	48.61	5.57	8.15	1.49	0.99	0.30	0.80
retinoblastoma cell line:Y79	10475-106I7	31.44	6.50	15.59	1.30	3.38	0.52	1.82
rhabdomyosarcoma cell line:KYM-1	10787-110H4	15.74	7.50	4.67	1.60	0.74	0.12	0.86
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	45.27	34.31	18.56	5.34	5.06	0.00	4.22
sacrococcigeal teratoma cell line:HTST	10695-109G2	18.95	12.88	6.06	0.76	1.52	0.76	0.00
salivary acinar cells, donor1	11771-123I7	14.89	4.37	4.86	0.00	0.81	0.00	0.16
salivary acinar cells, donor2	11772-123I8	18.17	4.68	3.44	0.14	0.55	0.00	0.55
salivary acinar cells, donor3	11773-123I9	19.20	7.94	4.63	1.32	0.00	0.00	0.66
salivary gland, adult, pool1	10093-102C3	22.31	12.01	16.59	1.72	2.29	0.00	2.29
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	12.39	1.85	4.64	0.17	0.42	0.08	0.08
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	10.70	2.94	5.17	0.47	0.24	0.82	0.47
seminal vesicle, adult	10201-103F3	28.57	6.88	10.05	0.53	0.53	0.53	0.53
serous adenocarcinoma cell line:JHOS-2	10639-108I9	27.69	12.39	8.02	1.46	0.97	0.49	0.73
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	13.08	17.36	7.30	0.25	1.26	1.26	1.01
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	14.05	8.03	8.03	0.00	0.00	0.00	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	25.25	22.30	6.98	3.63	0.94	0.13	0.40
signet ring carcinoma cell line:Kato III	10436-106E4	20.45	6.19	8.40	0.44	0.22	0.99	0.44
signet ring carcinoma cell line:NUGC-4	10483-107A6	22.19	13.03	6.58	0.90	1.29	0.13	1.03
skeletal muscle - soleus muscle, donor1	10282-104F3	12.77	2.84	7.09	0.00	0.00	0.00	0.71
skeletal muscle, adult, pool1	10023-101D5	22.79	3.48	6.00	0.24	1.20	0.24	0.72
skeletal muscle, fetal, donor1	10066-101I3	17.09	9.05	8.04	0.00	0.00	0.00	0.00
skin, adult, donor1	10074-102A2	27.14	6.79	13.57	0.00	0.00	0.00	6.79
skin, fetal, donor1	10065-101I2	23.36	8.21	13.26	1.26	1.26	0.00	2.52
small cell cervical cancer cell line:HCSC-1	10800-110I8	17.68	2.33	4.00	0.33	0.33	0.67	0.67
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	32.78	17.97	16.08	1.26	1.58	0.32	1.26
small cell lung carcinoma cell line:DMS 144	10841-111E4	144.56	6.94	5.20	3.66	1.93	0.00	2.31
small cell lung carcinoma cell line:LK-2	10541-107H1	35.11	18.63	23.74	2.31	1.98	0.99	1.48
small cell lung carcinoma cell line:NCI-H82	10842-111E5	23.00	4.83	17.53	1.77	2.57	1.29	1.77
small cell lung carcinoma cell line:WA-hT	10562-108A4	27.68	11.77	21.57	1.53	1.74	4.79	1.31
small intestine, adult, pool1	10024-101D6	39.77	4.78	6.81	1.19	0.36	0.24	0.72
small intestine, fetal, donor1	10064-101I1	16.22	3.69	6.14	0.74	0.74	0.00	0.74
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	18.46	10.77	12.82	4.62	3.08	0.00	1.54
smooth muscle, adult, pool1	10048-101G3	24.81	9.30	13.18	2.07	1.81	0.00	2.07
somatostatinoma cell line:QGP-1	10781-110G7	12.87	10.45	35.65	0.80	2.41	1.61	1.34
spinal cord - adult, donor10196	10181-103D1	18.58	4.36	6.88	1.15	0.92	0.23	0.92
spinal cord, adult, donor10252	10159-103A6	44.16	1.97	5.13	0.39	0.00	0.00	0.39
spinal cord, adult, donor10258	10369-105F9	15.91	3.46	7.61	0.00	1.38	0.00	0.00
spinal cord, fetal, donor1	10056-101H2	34.76	2.44	4.88	0.61	0.00	1.22	0.61
spinal cord, newborn, donor10223	10359-105E8	35.82	6.43	5.05	1.38	2.30	0.92	1.38
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	14.19	4.33	2.69	0.15	0.75	0.00	0.00
spleen, adult, pool1	10025-101D7	33.81	12.45	14.43	1.65	1.65	1.10	0.55
spleen, fetal, pool1	10044-101F8	48.94	17.48	14.94	2.15	1.11	0.79	1.03
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	35.92	16.77	6.94	1.45	1.97	0.21	0.41
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	25.82	19.75	11.20	2.28	1.90	0.76	1.52
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	20.97	34.25	6.64	2.80	1.05	0.70	1.75
squamous cell carcinoma cell line:T3M-5	10616-108G4	12.12	19.16	16.81	2.35	1.95	2.74	1.95
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	41.42	33.32	41.87	5.07	4.16	5.29	2.25
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	17.37	15.67	10.59	0.85	1.69	0.00	0.85
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	19.04	17.77	14.81	1.69	1.69	1.69	0.42
stomach, fetal, donor1	10062-101H8	16.02	4.27	13.88	1.07	1.07	0.00	1.07
submaxillary gland, adult	10202-103F4	33.61	10.82	13.10	0.57	1.71	0.57	0.57
substantia nigra - adult, donor10196	10178-103C7	0.00	0.00	0.00	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	49.43	2.08	2.91	0.00	0.42	0.21	0.62
substantia nigra, adult, donor10258	10371-105G2	9.83	8.28	5.69	1.03	0.52	0.52	1.55
substantia nigra, newborn, donor10223	10358-105E7	23.32	7.07	3.53	0.00	0.71	0.71	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	20.86	10.32	8.71	1.15	0.92	0.23	2.52
temporal lobe, adult, pool1	10031-101E4	27.97	8.73	11.44	3.31	0.76	0.08	2.12
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	35.61	4.99	28.49	0.71	0.00	0.00	3.56
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	35.60	3.96	28.13	0.00	1.32	0.44	3.08
tenocyte, donor1	11763-123H8	16.06	3.84	3.84	0.00	0.35	0.00	1.40
tenocyte, donor2	11765-123I1	8.77	2.29	1.53	0.00	0.00	0.00	0.00
tenocyte, donor3	11768-123I4	10.01	2.97	2.22	0.00	0.37	0.00	0.37
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	12.58	17.17	5.95	2.55	1.36	0.68	0.34
teratocarcinoma cell line:NCR-G1	10798-110I6	12.33	5.40	3.39	0.31	1.08	0.15	0.62
teratocarcinoma cell line:PA-1	10807-111A6	15.34	6.35	2.94	1.55	0.62	0.31	0.31
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	13.58	21.20	10.28	2.41	1.14	1.14	0.76
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	9.45	13.61	11.35	2.27	0.76	0.00	1.51
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	11.67	12.11	7.42	1.64	0.76	0.33	0.76
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	27.68	12.70	16.29	0.98	1.30	1.30	2.93
testis, adult, pool1	10026-101D8	39.41	2.79	4.08	0.86	0.54	0.43	0.64
testis, adult, pool2	10096-102C6	55.93	1.80	8.57	1.80	0.45	4.06	0.90
thalamus - adult, donor10196	10168-103B6	18.77	4.42	7.73	0.00	0.00	0.00	1.10
thalamus, adult, donor10252	10154-103A1	51.73	2.97	4.22	1.25	0.31	0.16	0.78
thalamus, adult, donor10258, tech_rep1	10370-105G1	29.25	1.54	7.70	0.00	0.00	0.00	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	11.53	1.15	2.47	0.99	0.82	0.00	0.33
thalamus, newborn, donor10223	10366-105F6	13.81	18.99	8.63	1.73	1.15	0.58	2.30
throat, adult	10209-103G2	26.71	7.49	9.99	0.50	2.00	0.25	1.00
throat, fetal, donor1	10061-101H7	25.29	5.79	11.58	0.91	0.61	0.30	1.22
thymic carcinoma cell line:Ty-82	10803-111A2	46.11	5.37	5.76	0.60	0.79	0.00	1.19
thymus, adult, pool1	10027-101D9	62.93	6.96	12.03	0.80	0.60	0.30	0.89
thymus, fetal, pool1	10043-101F7	90.92	10.49	8.94	1.04	0.73	0.21	0.31
thyroid carcinoma cell line:KHM-5M	10776-110G2	27.26	10.64	10.50	0.53	1.20	0.40	0.13
thyroid carcinoma cell line:TCO-1	10783-110G9	23.47	8.94	8.52	0.56	1.12	1.26	0.84
thyroid, adult, pool1	10028-101E1	35.37	8.02	7.84	1.40	1.49	0.19	1.40
thyroid, fetal, donor1	10060-101H6	25.84	8.96	14.24	1.58	1.05	1.32	1.58
tongue epidermis (fungiform papillae), donor1	10288-104F9	24.64	0.00	15.40	0.00	0.00	0.00	3.08
tongue, adult	10203-103F5	23.26	9.30	6.98	1.86	1.16	0.47	1.16
tongue, fetal, donor1	10059-101H5	24.04	5.12	6.70	0.79	0.39	0.39	0.39
tonsil, adult, pool1	10047-101G2	56.20	21.74	25.14	2.30	2.20	1.60	1.60
trachea, adult, pool1	10029-101E2	32.72	7.44	7.93	1.06	0.82	0.57	0.65
trachea, fetal, donor1	10058-101H4	30.01	6.54	13.46	0.00	1.54	0.38	1.54
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	14.53	10.27	4.25	1.42	0.35	0.00	0.71
transitional-cell carcinoma cell line:5637	10418-106C4	24.42	17.02	10.94	1.62	0.71	0.30	0.30
transitional-cell carcinoma cell line:JMSU1	10492-107B6	16.77	12.53	13.63	1.88	2.04	1.25	1.10
tridermal teratoma cell line:HGRT	10694-109G1	9.51	32.34	5.71	0.00	3.81	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	19.38	7.70	9.40	0.76	0.93	0.17	0.59
umbilical cord, fetal, donor1	10057-101H3	16.69	10.43	0.00	0.00	0.00	0.00	2.09
uterus, adult, pool1	10100-102D1	37.88	9.90	17.57	1.88	1.02	1.02	2.56
uterus, fetal, donor1	10055-101H1	26.62	2.56	1.54	0.00	0.00	0.00	0.00
vagina, adult	10204-103F6	28.43	9.05	9.05	2.58	0.65	0.00	1.29
vein, adult	10191-103E2	28.06	15.56	15.56	2.41	1.53	0.44	0.44
xeroderma pigentosum b cell line:XPL 17	10563-108A5	14.95	8.81	3.74	0.53	0.00	0.53	0.00